papers/abateDistinctViralMutational2015a.md
... ...
@@ -35,7 +35,7 @@ All other BL studies, BL Tier 2, 156
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[CCNF](CCNF)|2 |
38
+|[CCNF](../CCNF)|2 |
39 39
40 40
# Details
41 41
papers/albuquerqueEnhancingKnowledgeDiscovery2017a.md
... ...
@@ -35,9 +35,9 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[BTK](BTK)|1 |
39
-|[TET2](TET2)|1 |
40
-|[TMSB4X](TMSB4X)|1 |
38
+|[BTK](../BTK)|1 |
39
+|[TET2](../TET2)|1 |
40
+|[TMSB4X](../TMSB4X)|1 |
41 41
42 42
# Details
43 43
papers/arthurGenomewideDiscoverySomatic2018.md
... ...
@@ -35,26 +35,26 @@ All other DLBCL studies, DLBCL Tier 2, 186
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[AICDA](AICDA)|2 |
39
-|[BCL7A](BCL7A)|1 |
40
-|[BIRC3](BIRC3)|2 |
41
-|[CD44](CD44)|2 |
42
-|[CD74](CD74)|2 |
43
-|[ETV6](ETV6)|1 |
44
-|[GRHPR](GRHPR)|1 |
45
-|[LCOR](LCOR)|1 |
46
-|[LPP](LPP)|2 |
47
-|[MALAT1](MALAT1)|2 |
48
-|[MEF2C](MEF2C)|1 |
49
-|[NEAT1](NEAT1)|2 |
50
-|[OSBPL10](OSBPL10)|1 |
51
-|[PIM2](PIM2)|1 |
52
-|[RFTN1](RFTN1)|2 |
53
-|[SERPINA9](SERPINA9)|2 |
54
-|[ST6GAL1](ST6GAL1)|2 |
55
-|[TBC1D4](TBC1D4)|2 |
56
-|[ZC3H12A](ZC3H12A)|1 |
57
-|[ZCCHC7](ZCCHC7)|2 |
38
+|[AICDA](../AICDA)|2 |
39
+|[BCL7A](../BCL7A)|1 |
40
+|[BIRC3](../BIRC3)|2 |
41
+|[CD44](../CD44)|2 |
42
+|[CD74](../CD74)|2 |
43
+|[ETV6](../ETV6)|1 |
44
+|[GRHPR](../GRHPR)|1 |
45
+|[LCOR](../LCOR)|1 |
46
+|[LPP](../LPP)|2 |
47
+|[MALAT1](../MALAT1)|2 |
48
+|[MEF2C](../MEF2C)|1 |
49
+|[NEAT1](../NEAT1)|2 |
50
+|[OSBPL10](../OSBPL10)|1 |
51
+|[PIM2](../PIM2)|1 |
52
+|[RFTN1](../RFTN1)|2 |
53
+|[SERPINA9](../SERPINA9)|2 |
54
+|[ST6GAL1](../ST6GAL1)|2 |
55
+|[TBC1D4](../TBC1D4)|2 |
56
+|[ZC3H12A](../ZC3H12A)|1 |
57
+|[ZCCHC7](../ZCCHC7)|2 |
58 58
59 59
# Details
60 60
papers/barariaCathepsinAlterationsInduce2020c.md
... ...
@@ -35,7 +35,7 @@ All other FL studies, FL Tier 2, 50
35 35
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38
-|[CTSS](CTSS)|1 |
38
+|[CTSS](../CTSS)|1 |
39 39
40 40
# Details
41 41
papers/beaLandscapeSomaticMutations2013.md
... ...
@@ -35,33 +35,33 @@ All other MCL studies, MCL Tier 2, 30
35 35
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38
-|[ABCA3](ABCA3)|2 |
39
-|[ABCC9](ABCC9)|2 |
40
-|[ATM](ATM)|1 |
41
-|[BIRC3](BIRC3)|1 |
42
-|[CCND1](CCND1)|1 |
43
-|[CHMP4C](CHMP4C)|2 |
44
-|[CRYBG3](CRYBG3)|2 |
45
-|[DCP1B](DCP1B)|2 |
46
-|[DLGAP2](DLGAP2)|2 |
47
-|[DNAJC6](DNAJC6)|2 |
48
-|[KCNC2](KCNC2)|2 |
49
-|[KIAA1671](KIAA1671)|2 |
50
-|[KMT2D](KMT2D)|1 |
51
-|[LUZP4](LUZP4)|2 |
52
-|[MEF2B](MEF2B)|1 |
53
-|[NOTCH1](NOTCH1)|1 |
54
-|[NOTCH2](NOTCH2)|1 |
55
-|[NSD2](NSD2)|1 |
56
-|[PCSK2](PCSK2)|2 |
57
-|[PDLIM3](PDLIM3)|2 |
58
-|[RGS4](RGS4)|2 |
59
-|[SLC17A6](SLC17A6)|2 |
60
-|[SP140](SP140)|1 |
61
-|[TLR2](TLR2)|1 |
62
-|[TNRC6B](TNRC6B)|2 |
63
-|[TP53](TP53)|1 |
64
-|[TRPM6](TRPM6)|2 |
38
+|[ABCA3](../ABCA3)|2 |
39
+|[ABCC9](../ABCC9)|2 |
40
+|[ATM](../ATM)|1 |
41
+|[BIRC3](../BIRC3)|1 |
42
+|[CCND1](../CCND1)|1 |
43
+|[CHMP4C](../CHMP4C)|2 |
44
+|[CRYBG3](../CRYBG3)|2 |
45
+|[DCP1B](../DCP1B)|2 |
46
+|[DLGAP2](../DLGAP2)|2 |
47
+|[DNAJC6](../DNAJC6)|2 |
48
+|[KCNC2](../KCNC2)|2 |
49
+|[KIAA1671](../KIAA1671)|2 |
50
+|[KMT2D](../KMT2D)|1 |
51
+|[LUZP4](../LUZP4)|2 |
52
+|[MEF2B](../MEF2B)|1 |
53
+|[NOTCH1](../NOTCH1)|1 |
54
+|[NOTCH2](../NOTCH2)|1 |
55
+|[NSD2](../NSD2)|1 |
56
+|[PCSK2](../PCSK2)|2 |
57
+|[PDLIM3](../PDLIM3)|2 |
58
+|[RGS4](../RGS4)|2 |
59
+|[SLC17A6](../SLC17A6)|2 |
60
+|[SP140](../SP140)|1 |
61
+|[TLR2](../TLR2)|1 |
62
+|[TNRC6B](../TNRC6B)|2 |
63
+|[TP53](../TP53)|1 |
64
+|[TRPM6](../TRPM6)|2 |
65 65
66 66
# Details
67 67
papers/bohleRoleEarlyBcell2013.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[EBF1](EBF1)|1 |
38
+|[EBF1](../EBF1)|1 |
39 39
40 40
# Details
41 41
papers/braggioGenomicAnalysisMarginal2012.md
... ...
@@ -35,7 +35,7 @@ All other MZL studies, MZL Tier 2, 74
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[ATM](ATM)|1 |
38
+|[ATM](../ATM)|1 |
39 39
40 40
# Details
41 41
papers/burkhardtClinicalRelevanceMolecular2022b.md
... ...
@@ -35,31 +35,31 @@ All other BL studies, BL Tier 2, 132
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ADAMTS5](ADAMTS5)|2 |
39
-|[ADNP](ADNP)|2 |
40
-|[AGO4](AGO4)|2 |
41
-|[BCL2](BCL2)|2 |
42
-|[BTG1](BTG1)|2 |
43
-|[CD79A](CD79A)|2 |
44
-|[CHD4](CHD4)|2 |
45
-|[CPXM2](CPXM2)|2 |
46
-|[E2F2](E2F2)|2 |
47
-|[EDNRB](EDNRB)|2 |
48
-|[ERAP1](ERAP1)|2 |
49
-|[HLA-DQB1](HLA-DQB1)|2 |
50
-|[KLHL26](KLHL26)|2 |
51
-|[NOA1](NOA1)|2 |
52
-|[PIM1](PIM1)|2 |
53
-|[PPP6R2](PPP6R2)|2 |
54
-|[PREX1](PREX1)|2 |
55
-|[REV3L](REV3L)|2 |
56
-|[RPL10](RPL10)|2 |
57
-|[SAL3](SAL3)|2 |
58
-|[TTN](TTN)|2 |
59
-|[VWA7](VWA7)|2 |
60
-|[ZAN](ZAN)|2 |
61
-|[ZBTB7A](ZBTB7A)|2 |
62
-|[ZNF85](ZNF85)|2 |
38
+|[ADAMTS5](../ADAMTS5)|2 |
39
+|[ADNP](../ADNP)|2 |
40
+|[AGO4](../AGO4)|2 |
41
+|[BCL2](../BCL2)|2 |
42
+|[BTG1](../BTG1)|2 |
43
+|[CD79A](../CD79A)|2 |
44
+|[CHD4](../CHD4)|2 |
45
+|[CPXM2](../CPXM2)|2 |
46
+|[E2F2](../E2F2)|2 |
47
+|[EDNRB](../EDNRB)|2 |
48
+|[ERAP1](../ERAP1)|2 |
49
+|[HLA-DQB1](../HLA-DQB1)|2 |
50
+|[KLHL26](../KLHL26)|2 |
51
+|[NOA1](../NOA1)|2 |
52
+|[PIM1](../PIM1)|2 |
53
+|[PPP6R2](../PPP6R2)|2 |
54
+|[PREX1](../PREX1)|2 |
55
+|[REV3L](../REV3L)|2 |
56
+|[RPL10](../RPL10)|2 |
57
+|[SAL3](../SAL3)|2 |
58
+|[TTN](../TTN)|2 |
59
+|[VWA7](../VWA7)|2 |
60
+|[ZAN](../ZAN)|2 |
61
+|[ZBTB7A](../ZBTB7A)|2 |
62
+|[ZNF85](../ZNF85)|2 |
63 63
64 64
# Details
65 65
papers/chapuyMolecularSubtypesDiffuse2018b.md
... ...
@@ -35,25 +35,25 @@ All other DLBCL studies, DLBCL Tier 2, 181
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CCL4](CCL4)|2 |
39
-|[COQ7](COQ7)|2 |
40
-|[CRIP1](CRIP1)|2 |
41
-|[DOCK1](DOCK1)|2 |
42
-|[FUT5](FUT5)|2 |
43
-|[GABRA2](GABRA2)|2 |
44
-|[HIST1H1B](HIST1H1B)|1 |
45
-|[IL6](IL6)|2 |
46
-|[LTB](LTB)|1 |
47
-|[LYN](LYN)|2 |
48
-|[NANOG](NANOG)|2 |
49
-|[NAV1](NAV1)|2 |
50
-|[NLRP8](NLRP8)|2 |
51
-|[PDE4DIP](PDE4DIP)|2 |
52
-|[PRPS1](PRPS1)|2 |
53
-|[RAD9A](RAD9A)|2 |
54
-|[SMEK1](SMEK1)|2 |
55
-|[TLR2](TLR2)|2 |
56
-|[ZNF423](ZNF423)|2 |
38
+|[CCL4](../CCL4)|2 |
39
+|[COQ7](../COQ7)|2 |
40
+|[CRIP1](../CRIP1)|2 |
41
+|[DOCK1](../DOCK1)|2 |
42
+|[FUT5](../FUT5)|2 |
43
+|[GABRA2](../GABRA2)|2 |
44
+|[HIST1H1B](../HIST1H1B)|1 |
45
+|[IL6](../IL6)|2 |
46
+|[LTB](../LTB)|1 |
47
+|[LYN](../LYN)|2 |
48
+|[NANOG](../NANOG)|2 |
49
+|[NAV1](../NAV1)|2 |
50
+|[NLRP8](../NLRP8)|2 |
51
+|[PDE4DIP](../PDE4DIP)|2 |
52
+|[PRPS1](../PRPS1)|2 |
53
+|[RAD9A](../RAD9A)|2 |
54
+|[SMEK1](../SMEK1)|2 |
55
+|[TLR2](../TLR2)|2 |
56
+|[ZNF423](../ZNF423)|2 |
57 57
58 58
# Details
59 59
papers/cheungAcquiredTNFRSF14Mutations2010a.md
... ...
@@ -24,11 +24,11 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, FL Tier 1, 1
27
+New Tier 1, DLBCL Tier 1, 1
28 28
This study, New Tier 2, 0
29
-New Tier 2, FL Tier 2, 0
30
-All other FL studies, FL Tier 1, 65
31
-All other FL studies, FL Tier 2, 50
29
+New Tier 2, DLBCL Tier 2, 0
30
+All other DLBCL studies, DLBCL Tier 1, 127
31
+All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34 34
... ...
@@ -36,7 +36,7 @@ All other FL studies, FL Tier 2, 50
36 36
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[TNFRSF14](TNFRSF14)|1 |1 |
39
+|[TNFRSF14](../TNFRSF14)|1 |1 |
40 40
41 41
# Details
42 42
papers/compagnoMutationsMultipleGenes2009a.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[TNFAIP3](TNFAIP3)|1 |
38
+|[TNFAIP3](../TNFAIP3)|1 |
39 39
40 40
# Details
41 41
papers/deschGenotypingCirculatingTumor2020.md
... ...
@@ -35,16 +35,16 @@ All other PMBL studies, PMBL Tier 2, 73
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ACTG1](ACTG1)|2 |
39
-|[CCND3](CCND3)|2 |
40
-|[CDH2](CDH2)|2 |
41
-|[EZR](EZR)|2 |
42
-|[HLA-A](HLA-A)|2 |
43
-|[IGLL5](IGLL5)|2 |
44
-|[KLF2](KLF2)|2 |
45
-|[KMT2D](KMT2D)|2 |
46
-|[LTB](LTB)|1 |
47
-|[MYB](MYB)|2 |
38
+|[ACTG1](../ACTG1)|2 |
39
+|[CCND3](../CCND3)|2 |
40
+|[CDH2](../CDH2)|2 |
41
+|[EZR](../EZR)|2 |
42
+|[HLA-A](../HLA-A)|2 |
43
+|[IGLL5](../IGLL5)|2 |
44
+|[KLF2](../KLF2)|2 |
45
+|[KMT2D](../KMT2D)|2 |
46
+|[LTB](../LTB)|1 |
47
+|[MYB](../MYB)|2 |
48 48
49 49
# Details
50 50
papers/dunsCharacterizationDLBCLPMBL2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|PMBL|6|8|
12 11
|DLBCL|8|3|
12
+|PMBL|6|8|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -34,22 +34,22 @@ All other PMBL studies, PMBL Tier 2, 74
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|PMBL tier|DLBCL tier|
37
+|New gene|DLBCL tier|PMBL tier|
38 38
|:-|:-:|:-:|
39
-|[BIRC3](BIRC3)|2 |2 |
40
-|[CD83](CD83)|1 |1 |
41
-|[CREBBP](CREBBP)|1 |1 |
42
-|[DUSP2](DUSP2)|1 |1 |
43
-|[FOXO1](FOXO1)|2 |1 |
44
-|[HRNR](HRNR)|2 | |
45
-|[IL4R](IL4R)|1 |1 |
46
-|[LPHN3](LPHN3)|2 | |
47
-|[MCL1](MCL1)|2 |2 |
48
-|[MYC](MYC)|2 |1 |
49
-|[PIM1](PIM1)|1 |1 |
50
-|[RFTN1](RFTN1)|2 |2 |
51
-|[SGK1](SGK1)|1 |1 |
52
-|[WDR87](WDR87)|2 | |
39
+|[BIRC3](../BIRC3)|2 |2 |
40
+|[CD83](../CD83)|1 |1 |
41
+|[CREBBP](../CREBBP)|1 |1 |
42
+|[DUSP2](../DUSP2)|1 |1 |
43
+|[FOXO1](../FOXO1)|1 |2 |
44
+|[HRNR](../HRNR)| |2 |
45
+|[IL4R](../IL4R)|1 |1 |
46
+|[LPHN3](../LPHN3)| |2 |
47
+|[MCL1](../MCL1)|2 |2 |
48
+|[MYC](../MYC)|1 |2 |
49
+|[PIM1](../PIM1)|1 |1 |
50
+|[RFTN1](../RFTN1)|2 |2 |
51
+|[SGK1](../SGK1)|1 |1 |
52
+|[WDR87](../WDR87)| |2 |
53 53
54 54
# Details
55 55
papers/ganapathiGeneticLandscapeDural2016.md
... ...
@@ -35,7 +35,7 @@ All other MZL studies, MZL Tier 2, 74
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[KLHL6](KLHL6)|1 |
38
+|[KLHL6](../KLHL6)|1 |
39 39
40 40
# Details
41 41
papers/gomezUltraDeepSequencingReveals2023.md
... ...
@@ -35,13 +35,13 @@ All other PMBL studies, PMBL Tier 2, 77
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ARID5B](ARID5B)|1 |
39
-|[AXDND1](AXDND1)|2 |
40
-|[CDH5](CDH5)|2 |
41
-|[DTX1](DTX1)|1 |
42
-|[HLA-C](HLA-C)|2 |
43
-|[LIMD2](LIMD2)|2 |
44
-|[OR13C2](OR13C2)|2 |
38
+|[ARID5B](../ARID5B)|1 |
39
+|[AXDND1](../AXDND1)|2 |
40
+|[CDH5](../CDH5)|2 |
41
+|[DTX1](../DTX1)|1 |
42
+|[HLA-C](../HLA-C)|2 |
43
+|[LIMD2](../LIMD2)|2 |
44
+|[OR13C2](../OR13C2)|2 |
45 45
46 46
# Details
47 47
papers/grandeGenomewideDiscoverySomatic2019.md
... ...
@@ -35,19 +35,19 @@ All other BL studies, BL Tier 2, 153
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[BACH2](BACH2)|2 |
39
-|[BCL7A](BCL7A)|1 |
40
-|[CDKN2A](CDKN2A)|2 |
41
-|[CHD8](CHD8)|1 |
42
-|[GNAI2](GNAI2)|1 |
43
-|[HIST1H1E](HIST1H1E)|2 |
44
-|[KMT2D](KMT2D)|1 |
45
-|[MIR142](MIR142)|2 |
46
-|[RFX7](RFX7)|1 |
47
-|[SIN3A](SIN3A)|1 |
48
-|[TCL1A](TCL1A)|1 |
49
-|[TFAP4](TFAP4)|1 |
50
-|[USP7](USP7)|1 |
38
+|[BACH2](../BACH2)|2 |
39
+|[BCL7A](../BCL7A)|1 |
40
+|[CDKN2A](../CDKN2A)|2 |
41
+|[CHD8](../CHD8)|1 |
42
+|[GNAI2](../GNAI2)|1 |
43
+|[HIST1H1E](../HIST1H1E)|2 |
44
+|[KMT2D](../KMT2D)|1 |
45
+|[MIR142](../MIR142)|2 |
46
+|[RFX7](../RFX7)|1 |
47
+|[SIN3A](../SIN3A)|1 |
48
+|[TCL1A](../TCL1A)|1 |
49
+|[TFAP4](../TFAP4)|1 |
50
+|[USP7](../USP7)|1 |
51 51
52 52
# Details
53 53
papers/gunawardanaRecurrentSomaticMutations2014c.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[PTPN1](PTPN1)|1 |
38
+|[PTPN1](../PTPN1)|1 |
39 39
40 40
# Details
41 41
papers/hubschmannMutationalMechanismsShaping2021b.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|FL|2|15|
12 11
|DLBCL|3|23|
12
+|FL|2|15|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -34,46 +34,46 @@ All other DLBCL studies, DLBCL Tier 2, 175
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|FL tier|DLBCL tier|
37
+|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[ACTG1](ACTG1)|2 |1 |
40
-|[ADAMTS1](ADAMTS1)| |2 |
41
-|[ANKRD12](ANKRD12)| |2 |
42
-|[ATP6V1A](ATP6V1A)|2 | |
43
-|[CADPS2](CADPS2)| |2 |
44
-|[CCDC42BPB](CCDC42BPB)|2 | |
45
-|[CNOT2](CNOT2)| |2 |
46
-|[CPNE8](CPNE8)|2 | |
47
-|[DHX15](DHX15)|2 | |
48
-|[DHX16](DHX16)| |2 |
49
-|[DNM2](DNM2)| |2 |
50
-|[EEF1A1](EEF1A1)|1 |1 |
51
-|[FBXO11](FBXO11)| |1 |
52
-|[FZR1](FZR1)|2 | |
53
-|[GAK](GAK)| |2 |
54
-|[HLA-DQA1](HLA-DQA1)| |2 |
55
-|[IKBKE](IKBKE)| |2 |
56
-|[IRF1](IRF1)| |2 |
57
-|[JUP](JUP)|2 | |
58
-|[LAPTM5](LAPTM5)|2 |2 |
59
-|[LRP12](LRP12)| |2 |
60
-|[MGEA5](MGEA5)|2 | |
61
-|[MYCBP2](MYCBP2)|2 | |
62
-|[N2RF2](N2RF2)| |2 |
63
-|[PDS5B](PDS5B)|2 |2 |
64
-|[PNPO](PNPO)| |2 |
65
-|[PPP4C](PPP4C)|2 | |
66
-|[PRKDC](PRKDC)|2 |2 |
67
-|[RAC2](RAC2)| |2 |
68
-|[RBM6](RBM6)|2 | |
69
-|[SIAH2](SIAH2)| |2 |
70
-|[SLC34A2](SLC34A2)| |2 |
71
-|[TPP1](TPP1)|2 | |
72
-|[TRAF6](TRAF6)| |2 |
73
-|[UNC5B](UNC5B)| |2 |
74
-|[VMA21](VMA21)|1 | |
75
-|[WNK1](WNK1)| |2 |
76
-|[ZNF217](ZNF217)| |2 |
39
+|[ACTG1](../ACTG1)|1 |2 |
40
+|[ADAMTS1](../ADAMTS1)|2 | |
41
+|[ANKRD12](../ANKRD12)|2 | |
42
+|[ATP6V1A](../ATP6V1A)| |2 |
43
+|[CADPS2](../CADPS2)|2 | |
44
+|[CCDC42BPB](../CCDC42BPB)| |2 |
45
+|[CNOT2](../CNOT2)|2 | |
46
+|[CPNE8](../CPNE8)| |2 |
47
+|[DHX15](../DHX15)| |2 |
48
+|[DHX16](../DHX16)|2 | |
49
+|[DNM2](../DNM2)|2 | |
50
+|[EEF1A1](../EEF1A1)|1 |1 |
51
+|[FBXO11](../FBXO11)|1 | |
52
+|[FZR1](../FZR1)| |2 |
53
+|[GAK](../GAK)|2 | |
54
+|[HLA-DQA1](../HLA-DQA1)|2 | |
55
+|[IKBKE](../IKBKE)|2 | |
56
+|[IRF1](../IRF1)|2 | |
57
+|[JUP](../JUP)| |2 |
58
+|[LAPTM5](../LAPTM5)|2 |2 |
59
+|[LRP12](../LRP12)|2 | |
60
+|[MGEA5](../MGEA5)| |2 |
61
+|[MYCBP2](../MYCBP2)| |2 |
62
+|[N2RF2](../N2RF2)|2 | |
63
+|[PDS5B](../PDS5B)|2 |2 |
64
+|[PNPO](../PNPO)|2 | |
65
+|[PPP4C](../PPP4C)| |2 |
66
+|[PRKDC](../PRKDC)|2 |2 |
67
+|[RAC2](../RAC2)|2 | |
68
+|[RBM6](../RBM6)| |2 |
69
+|[SIAH2](../SIAH2)|2 | |
70
+|[SLC34A2](../SLC34A2)|2 | |
71
+|[TPP1](../TPP1)| |2 |
72
+|[TRAF6](../TRAF6)|2 | |
73
+|[UNC5B](../UNC5B)|2 | |
74
+|[VMA21](../VMA21)| |1 |
75
+|[WNK1](../WNK1)|2 | |
76
+|[ZNF217](../ZNF217)|2 | |
77 77
78 78
# Details
79 79
papers/jalladesExomeSequencingIdentifies2017.md
... ...
@@ -35,34 +35,34 @@ All other MZL studies, MZL Tier 2, 48
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[ARHGAP20](ARHGAP20)|2 |
39
-|[ARHGEF15](ARHGEF15)|2 |
40
-|[ARHGEF17](ARHGEF17)|2 |
41
-|[BCOR](BCOR)|2 |
42
-|[CCND3](CCND3)|1 |
43
-|[DNAH5](DNAH5)|2 |
44
-|[DNAH7](DNAH7)|2 |
45
-|[DNAI1](DNAI1)|2 |
46
-|[DOCK6](DOCK6)|2 |
47
-|[DTX3L](DTX3L)|2 |
48
-|[EZH1](EZH1)|2 |
49
-|[HIST1H1D](HIST1H1D)|2 |
50
-|[HIST1H2AD](HIST1H2AD)|2 |
51
-|[HIST4H4](HIST4H4)|2 |
52
-|[HRAS](HRAS)|2 |
53
-|[KAT6A](KAT6A)|2 |
54
-|[KDM6A](KDM6A)|2 |
55
-|[KIF26A](KIF26A)|2 |
56
-|[KLF2](KLF2)|1 |
57
-|[MGA](MGA)|2 |
58
-|[MYC](MYC)|2 |
59
-|[MYLK](MYLK)|2 |
60
-|[NCOA6](NCOA6)|2 |
61
-|[NRAS](NRAS)|2 |
62
-|[RAF1](RAF1)|2 |
63
-|[ROCK1](ROCK1)|2 |
64
-|[TBK1](TBK1)|2 |
65
-|[WNK1](WNK1)|2 |
38
+|[ARHGAP20](../ARHGAP20)|2 |
39
+|[ARHGEF15](../ARHGEF15)|2 |
40
+|[ARHGEF17](../ARHGEF17)|2 |
41
+|[BCOR](../BCOR)|2 |
42
+|[CCND3](../CCND3)|1 |
43
+|[DNAH5](../DNAH5)|2 |
44
+|[DNAH7](../DNAH7)|2 |
45
+|[DNAI1](../DNAI1)|2 |
46
+|[DOCK6](../DOCK6)|2 |
47
+|[DTX3L](../DTX3L)|2 |
48
+|[EZH1](../EZH1)|2 |
49
+|[HIST1H1D](../HIST1H1D)|2 |
50
+|[HIST1H2AD](../HIST1H2AD)|2 |
51
+|[HIST4H4](../HIST4H4)|2 |
52
+|[HRAS](../HRAS)|2 |
53
+|[KAT6A](../KAT6A)|2 |
54
+|[KDM6A](../KDM6A)|2 |
55
+|[KIF26A](../KIF26A)|2 |
56
+|[KLF2](../KLF2)|1 |
57
+|[MGA](../MGA)|2 |
58
+|[MYC](../MYC)|2 |
59
+|[MYLK](../MYLK)|2 |
60
+|[NCOA6](../NCOA6)|2 |
61
+|[NRAS](../NRAS)|2 |
62
+|[RAF1](../RAF1)|2 |
63
+|[ROCK1](../ROCK1)|2 |
64
+|[TBK1](../TBK1)|2 |
65
+|[WNK1](../WNK1)|2 |
66 66
67 67
# Details
68 68
papers/jardinRecurrentMutationsExportin2016a.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[XPO1](XPO1)|1 |
38
+|[XPO1](../XPO1)|1 |
39 39
40 40
# Details
41 41
papers/johnstonCmycHypermutationBurkitt1992.md
... ...
@@ -35,7 +35,7 @@ All other BL studies, BL Tier 2, 157
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[MYC](MYC)|1 |
38
+|[MYC](../MYC)|1 |
39 39
40 40
# Details
41 41
papers/khodabakhshiRecurrentTargetsAberrant2012.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CXCR4](CXCR4)|1 |
38
+|[CXCR4](../CXCR4)|1 |
39 39
40 40
# Details
41 41
papers/krysiakRecurrentSomaticMutations2017b.md
... ...
@@ -35,28 +35,28 @@ All other FL studies, FL Tier 2, 45
35 35
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38
-|[ARID1A](ARID1A)|1 |
39
-|[BCL7A](BCL7A)|1 |
40
-|[BTK](BTK)|1 |
41
-|[CXCR4](CXCR4)|2 |
42
-|[EGR1](EGR1)|2 |
43
-|[HIST1H1B](HIST1H1B)|1 |
44
-|[HIST1H1D](HIST1H1D)|1 |
45
-|[HIST1H1E](HIST1H1E)|1 |
46
-|[HIST1H2AC](HIST1H2AC)|1 |
47
-|[HIST1H2AG](HIST1H2AG)|1 |
48
-|[HIST1H2AM](HIST1H2AM)|1 |
49
-|[HIST1H2BC](HIST1H2BC)|1 |
50
-|[HIST1H2BD](HIST1H2BD)|1 |
51
-|[HIST1H2BG](HIST1H2BG)|1 |
52
-|[HIST1H2BM](HIST1H2BM)|2 |
53
-|[HIST1H3G](HIST1H3G)|1 |
54
-|[HIST1H3I](HIST1H3I)|2 |
55
-|[HVCN1](HVCN1)|1 |
56
-|[POU2AF1](POU2AF1)|1 |
57
-|[POU2F2](POU2F2)|1 |
58
-|[SMARCA4](SMARCA4)|1 |
59
-|[ZNF608](ZNF608)|2 |
38
+|[ARID1A](../ARID1A)|1 |
39
+|[BCL7A](../BCL7A)|1 |
40
+|[BTK](../BTK)|1 |
41
+|[CXCR4](../CXCR4)|2 |
42
+|[EGR1](../EGR1)|2 |
43
+|[HIST1H1B](../HIST1H1B)|1 |
44
+|[HIST1H1D](../HIST1H1D)|1 |
45
+|[HIST1H1E](../HIST1H1E)|1 |
46
+|[HIST1H2AC](../HIST1H2AC)|1 |
47
+|[HIST1H2AG](../HIST1H2AG)|1 |
48
+|[HIST1H2AM](../HIST1H2AM)|1 |
49
+|[HIST1H2BC](../HIST1H2BC)|1 |
50
+|[HIST1H2BD](../HIST1H2BD)|1 |
51
+|[HIST1H2BG](../HIST1H2BG)|1 |
52
+|[HIST1H2BM](../HIST1H2BM)|2 |
53
+|[HIST1H3G](../HIST1H3G)|1 |
54
+|[HIST1H3I](../HIST1H3I)|2 |
55
+|[HVCN1](../HVCN1)|1 |
56
+|[POU2AF1](../POU2AF1)|1 |
57
+|[POU2F2](../POU2F2)|1 |
58
+|[SMARCA4](../SMARCA4)|1 |
59
+|[ZNF608](../ZNF608)|2 |
60 60
61 61
# Details
62 62
papers/kwanhianMicroRNA142Mutated202012b.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 197
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[MIR142](MIR142)|2 |
38
+|[MIR142](../MIR142)|2 |
39 39
40 40
# Details
41 41
papers/lakeMutationsNFKBIAEncoding2009.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[NFKBIA](NFKBIA)|1 |
38
+|[NFKBIA](../NFKBIA)|1 |
39 39
40 40
# Details
41 41
papers/lenzOncogenicCARD11Mutations2008.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CARD11](CARD11)|1 |
38
+|[CARD11](../CARD11)|1 |
39 39
40 40
# Details
41 41
papers/lohrDiscoveryPrioritizationSomatic2012a.md
... ...
@@ -35,10 +35,10 @@ All other DLBCL studies, DLBCL Tier 2, 197
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[ACTB](ACTB)|1 |
39
-|[KRAS](KRAS)|1 |
40
-|[P2RY8](P2RY8)|1 |
41
-|[PCLO](PCLO)|2 |
38
+|[ACTB](../ACTB)|1 |
39
+|[KRAS](../KRAS)|1 |
40
+|[P2RY8](../P2RY8)|1 |
41
+|[PCLO](../PCLO)|2 |
42 42
43 43
# Details
44 44
papers/louissaintPediatrictypeNodalFollicular2016a.md
... ...
@@ -35,7 +35,7 @@ All other FL studies, FL Tier 2, 50
35 35
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38
-|[MAP2K1](MAP2K1)|1 |
38
+|[MAP2K1](../MAP2K1)|1 |
39 39
40 40
# Details
41 41
papers/loveGeneticLandscapeMutations2012.md
... ...
@@ -35,65 +35,65 @@ All other BL studies, BL Tier 2, 101
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ACAD9](ACAD9)|2 |
39
-|[ACE](ACE)|2 |
40
-|[ARID1A](ARID1A)|1 |
41
-|[ATP2C2](ATP2C2)|2 |
42
-|[BCL6](BCL6)|2 |
43
-|[BRAF](BRAF)|2 |
44
-|[BRD4](BRD4)|2 |
45
-|[BTG2](BTG2)|2 |
46
-|[C6orf27](C6orf27)|2 |
47
-|[CAD](CAD)|2 |
48
-|[CARD4](CARD4)|2 |
49
-|[CCT6B](CCT6B)|2 |
50
-|[CDC73](CDC73)|2 |
51
-|[CDH17](CDH17)|2 |
52
-|[COL4A2](COL4A2)|2 |
53
-|[CREBBP](CREBBP)|2 |
54
-|[CYB5D1](CYB5D1)|2 |
55
-|[CYP4F22](CYP4F22)|2 |
56
-|[DLGAP1](DLGAP1)|2 |
57
-|[EIF2C4](EIF2C4)|2 |
58
-|[EML2](EML2)|2 |
59
-|[ENTPD3](ENTPD3)|2 |
60
-|[EPHB2](EPHB2)|2 |
61
-|[EZH2](EZH2)|2 |
62
-|[FAM129B](FAM129B)|2 |
63
-|[FGFR3](FGFR3)|2 |
64
-|[FTCD](FTCD)|2 |
65
-|[GGTLA4](GGTLA4)|2 |
66
-|[GNA13](GNA13)|1 |
67
-|[GRIK5](GRIK5)|2 |
68
-|[ICK](ICK)|2 |
69
-|[ITPR3](ITPR3)|2 |
70
-|[KIFC3](KIFC3)|2 |
71
-|[MAP3K6](MAP3K6)|2 |
72
-|[MYH10](MYH10)|2 |
73
-|[NBEAL1](NBEAL1)|2 |
74
-|[NOTCH1](NOTCH1)|2 |
75
-|[NRXN2](NRXN2)|2 |
76
-|[P2RY2](P2RY2)|2 |
77
-|[PC](PC)|2 |
78
-|[POLRMT](POLRMT)|2 |
79
-|[POR](POR)|2 |
80
-|[PRSS22](PRSS22)|2 |
81
-|[PTEN](PTEN)|1 |
82
-|[PTPRN](PTPRN)|2 |
83
-|[RANBP6](RANBP6)|2 |
84
-|[RBP3](RBP3)|2 |
85
-|[RET](RET)|2 |
86
-|[SALL3](SALL3)|2 |
87
-|[SAPS2](SAPS2)|2 |
88
-|[SBF1](SBF1)|2 |
89
-|[SF3B1](SF3B1)|2 |
90
-|[SHANK1](SHANK1)|2 |
91
-|[SLC29A2](SLC29A2)|2 |
92
-|[SYNGAP1](SYNGAP1)|2 |
93
-|[TBC1D9B](TBC1D9B)|2 |
94
-|[TIGD6](TIGD6)|2 |
95
-|[TPST2](TPST2)|2 |
96
-|[ZNF229](ZNF229)|2 |
38
+|[ACAD9](../ACAD9)|2 |
39
+|[ACE](../ACE)|2 |
40
+|[ARID1A](../ARID1A)|1 |
41
+|[ATP2C2](../ATP2C2)|2 |
42
+|[BCL6](../BCL6)|2 |
43
+|[BRAF](../BRAF)|2 |
44
+|[BRD4](../BRD4)|2 |
45
+|[BTG2](../BTG2)|2 |
46
+|[C6orf27](../C6orf27)|2 |
47
+|[CAD](../CAD)|2 |
48
+|[CARD4](../CARD4)|2 |
49
+|[CCT6B](../CCT6B)|2 |
50
+|[CDC73](../CDC73)|2 |
51
+|[CDH17](../CDH17)|2 |
52
+|[COL4A2](../COL4A2)|2 |
53
+|[CREBBP](../CREBBP)|2 |
54
+|[CYB5D1](../CYB5D1)|2 |
55
+|[CYP4F22](../CYP4F22)|2 |
56
+|[DLGAP1](../DLGAP1)|2 |
57
+|[EIF2C4](../EIF2C4)|2 |
58
+|[EML2](../EML2)|2 |
59
+|[ENTPD3](../ENTPD3)|2 |
60
+|[EPHB2](../EPHB2)|2 |
61
+|[EZH2](../EZH2)|2 |
62
+|[FAM129B](../FAM129B)|2 |
63
+|[FGFR3](../FGFR3)|2 |
64
+|[FTCD](../FTCD)|2 |
65
+|[GGTLA4](../GGTLA4)|2 |
66
+|[GNA13](../GNA13)|1 |
67
+|[GRIK5](../GRIK5)|2 |
68
+|[ICK](../ICK)|2 |
69
+|[ITPR3](../ITPR3)|2 |
70
+|[KIFC3](../KIFC3)|2 |
71
+|[MAP3K6](../MAP3K6)|2 |
72
+|[MYH10](../MYH10)|2 |
73
+|[NBEAL1](../NBEAL1)|2 |
74
+|[NOTCH1](../NOTCH1)|2 |
75
+|[NRXN2](../NRXN2)|2 |
76
+|[P2RY2](../P2RY2)|2 |
77
+|[PC](../PC)|2 |
78
+|[POLRMT](../POLRMT)|2 |
79
+|[POR](../POR)|2 |
80
+|[PRSS22](../PRSS22)|2 |
81
+|[PTEN](../PTEN)|1 |
82
+|[PTPRN](../PTPRN)|2 |
83
+|[RANBP6](../RANBP6)|2 |
84
+|[RBP3](../RBP3)|2 |
85
+|[RET](../RET)|2 |
86
+|[SALL3](../SALL3)|2 |
87
+|[SAPS2](../SAPS2)|2 |
88
+|[SBF1](../SBF1)|2 |
89
+|[SF3B1](../SF3B1)|2 |
90
+|[SHANK1](../SHANK1)|2 |
91
+|[SLC29A2](../SLC29A2)|2 |
92
+|[SYNGAP1](../SYNGAP1)|2 |
93
+|[TBC1D9B](../TBC1D9B)|2 |
94
+|[TIGD6](../TIGD6)|2 |
95
+|[TPST2](../TPST2)|2 |
96
+|[ZNF229](../ZNF229)|2 |
97 97
98 98
# Details
99 99
papers/mansouriFrequentNFKBIEDeletions2016.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[NFKBIE](NFKBIE)|1 |
38
+|[NFKBIE](../NFKBIE)|1 |
39 39
40 40
# Details
41 41
papers/mareschalWholeExomeSequencing2016.md
... ...
@@ -35,8 +35,8 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[TBL1XR1](TBL1XR1)|1 |
39
-|[XPO1](XPO1)|1 |
38
+|[TBL1XR1](../TBL1XR1)|1 |
39
+|[XPO1](../XPO1)|1 |
40 40
41 41
# Details
42 42
papers/morinFrequentMutationHistonemodifying2011.md
... ...
@@ -36,34 +36,34 @@ All other DLBCL studies, DLBCL Tier 2, 197
36 36
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[B2M](B2M)|1 |1 |
40
-|[BCL10](BCL10)|1 |2 |
41
-|[BCL2](BCL2)|1 |1 |
42
-|[BCL6](BCL6)|1 |1 |
43
-|[BTG1](BTG1)|1 |1 |
44
-|[BTG2](BTG2)|1 |1 |
45
-|[CARD11](CARD11)|1 |1 |
46
-|[CCND3](CCND3)|1 |1 |
47
-|[CD274](CD274)|2 | |
48
-|[CD58](CD58)|1 | |
49
-|[CD70](CD70)|1 |2 |
50
-|[CD79B](CD79B)|1 |2 |
51
-|[CIITA](CIITA)|1 | |
52
-|[ETS1](ETS1)|1 | |
53
-|[FOXO1](FOXO1)|1 |1 |
54
-|[GNA13](GNA13)|1 |1 |
55
-|[HIST1H1C](HIST1H1C)|1 |1 |
56
-|[IRF4](IRF4)|1 |1 |
57
-|[IRF8](IRF8)|1 |1 |
58
-|[KLHL6](KLHL6)|1 |1 |
59
-|[KMT2D](KMT2D)|1 |1 |
60
-|[MEF2B](MEF2B)|1 |1 |
61
-|[S1PR2](S1PR2)|1 |1 |
62
-|[SGK1](SGK1)|1 |1 |
63
-|[SOCS1](SOCS1)|1 |1 |
64
-|[TMEM30A](TMEM30A)|1 |2 |
65
-|[TP53](TP53)|1 |1 |
66
-|[ZFP36L1](ZFP36L1)|1 | |
39
+|[B2M](../B2M)|1 |1 |
40
+|[BCL10](../BCL10)|1 |2 |
41
+|[BCL2](../BCL2)|1 |1 |
42
+|[BCL6](../BCL6)|1 |1 |
43
+|[BTG1](../BTG1)|1 |1 |
44
+|[BTG2](../BTG2)|1 |1 |
45
+|[CARD11](../CARD11)|1 |1 |
46
+|[CCND3](../CCND3)|1 |1 |
47
+|[CD274](../CD274)|2 | |
48
+|[CD58](../CD58)|1 | |
49
+|[CD70](../CD70)|1 |2 |
50
+|[CD79B](../CD79B)|1 |2 |
51
+|[CIITA](../CIITA)|1 | |
52
+|[ETS1](../ETS1)|1 | |
53
+|[FOXO1](../FOXO1)|1 |1 |
54
+|[GNA13](../GNA13)|1 |1 |
55
+|[HIST1H1C](../HIST1H1C)|1 |1 |
56
+|[IRF4](../IRF4)|1 |1 |
57
+|[IRF8](../IRF8)|1 |1 |
58
+|[KLHL6](../KLHL6)|1 |1 |
59
+|[KMT2D](../KMT2D)|1 |1 |
60
+|[MEF2B](../MEF2B)|1 |1 |
61
+|[S1PR2](../S1PR2)|1 |1 |
62
+|[SGK1](../SGK1)|1 |1 |
63
+|[SOCS1](../SOCS1)|1 |1 |
64
+|[TMEM30A](../TMEM30A)|1 |2 |
65
+|[TP53](../TP53)|1 |1 |
66
+|[ZFP36L1](../ZFP36L1)|1 | |
67 67
68 68
# Details
69 69
papers/morinGeneticLandscapesRelapsed2016.md
... ...
@@ -35,8 +35,8 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[NFKBIE](NFKBIE)|1 |
39
-|[NFKBIZ](NFKBIZ)|1 |
38
+|[NFKBIE](../NFKBIE)|1 |
39
+|[NFKBIZ](../NFKBIZ)|1 |
40 40
41 41
# Details
42 42
papers/morinMutationalStructuralAnalysis2013.md
... ...
@@ -35,46 +35,46 @@ All other DLBCL studies, DLBCL Tier 2, 169
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[ABI3BP](ABI3BP)|2 |
39
-|[CD83](CD83)|1 |
40
-|[CDH9](CDH9)|2 |
41
-|[CDKN2A](CDKN2A)|1 |
42
-|[CNTNAP5](CNTNAP5)|2 |
43
-|[DNAH5](DNAH5)|2 |
44
-|[DSG4](DSG4)|2 |
45
-|[DUSP2](DUSP2)|1 |
46
-|[FAM38B](FAM38B)|2 |
47
-|[FAT4](FAT4)|2 |
48
-|[FNDC1](FNDC1)|2 |
49
-|[GNAI2](GNAI2)|1 |
50
-|[HDAC7](HDAC7)|2 |
51
-|[HIST1H1D](HIST1H1D)|1 |
52
-|[HIST1H1E](HIST1H1E)|1 |
53
-|[HIST1H2AC](HIST1H2AC)|1 |
54
-|[HIST1H2AG](HIST1H2AG)|2 |
55
-|[IER2](IER2)|2 |
56
-|[IFNGR1](IFNGR1)|2 |
57
-|[IKZF3](IKZF3)|1 |
58
-|[LRRN3](LRRN3)|2 |
59
-|[MPDZ](MPDZ)|2 |
60
-|[MPEG1](MPEG1)|1 |
61
-|[NLRP5](NLRP5)|2 |
62
-|[ODZ3](ODZ3)|2 |
63
-|[P2RX5](P2RX5)|2 |
64
-|[PASK](PASK)|2 |
65
-|[PCDHB11](PCDHB11)|2 |
66
-|[PDS5B](PDS5B)|2 |
67
-|[PKD1](PKD1)|2 |
68
-|[POGZ](POGZ)|2 |
69
-|[PRKCB](PRKCB)|2 |
70
-|[PTPN23](PTPN23)|2 |
71
-|[RB1](RB1)|1 |
72
-|[SAMD9L](SAMD9L)|2 |
73
-|[SARM1](SARM1)|2 |
74
-|[SRRM2](SRRM2)|2 |
75
-|[SYPL1](SYPL1)|2 |
76
-|[TAF1](TAF1)|1 |
77
-|[WDFY3](WDFY3)|2 |
38
+|[ABI3BP](../ABI3BP)|2 |
39
+|[CD83](../CD83)|1 |
40
+|[CDH9](../CDH9)|2 |
41
+|[CDKN2A](../CDKN2A)|1 |
42
+|[CNTNAP5](../CNTNAP5)|2 |
43
+|[DNAH5](../DNAH5)|2 |
44
+|[DSG4](../DSG4)|2 |
45
+|[DUSP2](../DUSP2)|1 |
46
+|[FAM38B](../FAM38B)|2 |
47
+|[FAT4](../FAT4)|2 |
48
+|[FNDC1](../FNDC1)|2 |
49
+|[GNAI2](../GNAI2)|1 |
50
+|[HDAC7](../HDAC7)|2 |
51
+|[HIST1H1D](../HIST1H1D)|1 |
52
+|[HIST1H1E](../HIST1H1E)|1 |
53
+|[HIST1H2AC](../HIST1H2AC)|1 |
54
+|[HIST1H2AG](../HIST1H2AG)|2 |
55
+|[IER2](../IER2)|2 |
56
+|[IFNGR1](../IFNGR1)|2 |
57
+|[IKZF3](../IKZF3)|1 |
58
+|[LRRN3](../LRRN3)|2 |
59
+|[MPDZ](../MPDZ)|2 |
60
+|[MPEG1](../MPEG1)|1 |
61
+|[NLRP5](../NLRP5)|2 |
62
+|[ODZ3](../ODZ3)|2 |
63
+|[P2RX5](../P2RX5)|2 |
64
+|[PASK](../PASK)|2 |
65
+|[PCDHB11](../PCDHB11)|2 |
66
+|[PDS5B](../PDS5B)|2 |
67
+|[PKD1](../PKD1)|2 |
68
+|[POGZ](../POGZ)|2 |
69
+|[PRKCB](../PRKCB)|2 |
70
+|[PTPN23](../PTPN23)|2 |
71
+|[RB1](../RB1)|1 |
72
+|[SAMD9L](../SAMD9L)|2 |
73
+|[SARM1](../SARM1)|2 |
74
+|[SRRM2](../SRRM2)|2 |
75
+|[SYPL1](../SYPL1)|2 |
76
+|[TAF1](../TAF1)|1 |
77
+|[WDFY3](../WDFY3)|2 |
78 78
79 79
# Details
80 80
papers/morinSomaticMutationsAltering2010a.md
... ...
@@ -24,11 +24,11 @@ config:
24 24
---
25 25
sankey-beta
26 26
This study, New Tier 1, 1
27
-New Tier 1, FL Tier 1, 1
27
+New Tier 1, DLBCL Tier 1, 1
28 28
This study, New Tier 2, 0
29
-New Tier 2, FL Tier 2, 0
30
-All other FL studies, FL Tier 1, 65
31
-All other FL studies, FL Tier 2, 50
29
+New Tier 2, DLBCL Tier 2, 0
30
+All other DLBCL studies, DLBCL Tier 1, 127
31
+All other DLBCL studies, DLBCL Tier 2, 198
32 32
```
33 33
34 34
... ...
@@ -36,7 +36,7 @@ All other FL studies, FL Tier 2, 50
36 36
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[EZH2](EZH2)|1 |1 |
39
+|[EZH2](../EZH2)|1 |1 |
40 40
41 41
# Details
42 42
papers/mottokGenomicAlterationsCIITA2015b.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[CIITA](CIITA)|1 |
38
+|[CIITA](../CIITA)|1 |
39 39
40 40
# Details
41 41
papers/mottokIntegrativeGenomicAnalysis2019b.md
... ...
@@ -35,27 +35,27 @@ All other PMBL studies, PMBL Tier 2, 67
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[CISH](CISH)|1 |
39
-|[CXCR5](CXCR5)|2 |
40
-|[DDX3X](DDX3X)|1 |
41
-|[EPHA7](EPHA7)|2 |
42
-|[EZH2](EZH2)|1 |
43
-|[GCSAM](GCSAM)|2 |
44
-|[HIST1H2BC](HIST1H2BC)|2 |
45
-|[HIST1H4E](HIST1H4E)|2 |
46
-|[HIST1H4J](HIST1H4J)|2 |
47
-|[IL13RA1](IL13RA1)|2 |
48
-|[IL1RAPL2](IL1RAPL2)|2 |
49
-|[IRF2BP2](IRF2BP2)|2 |
50
-|[IRF4](IRF4)|2 |
51
-|[IRF8](IRF8)|1 |
52
-|[JAK1](JAK1)|1 |
53
-|[JUNB](JUNB)|2 |
54
-|[MAGEC2](MAGEC2)|2 |
55
-|[MS4A1](MS4A1)|1 |
56
-|[NFKB2](NFKB2)|2 |
57
-|[RGS1](RGS1)|2 |
58
-|[VMP1](VMP1)|2 |
38
+|[CISH](../CISH)|1 |
39
+|[CXCR5](../CXCR5)|2 |
40
+|[DDX3X](../DDX3X)|1 |
41
+|[EPHA7](../EPHA7)|2 |
42
+|[EZH2](../EZH2)|1 |
43
+|[GCSAM](../GCSAM)|2 |
44
+|[HIST1H2BC](../HIST1H2BC)|2 |
45
+|[HIST1H4E](../HIST1H4E)|2 |
46
+|[HIST1H4J](../HIST1H4J)|2 |
47
+|[IL13RA1](../IL13RA1)|2 |
48
+|[IL1RAPL2](../IL1RAPL2)|2 |
49
+|[IRF2BP2](../IRF2BP2)|2 |
50
+|[IRF4](../IRF4)|2 |
51
+|[IRF8](../IRF8)|1 |
52
+|[JAK1](../JAK1)|1 |
53
+|[JUNB](../JUNB)|2 |
54
+|[MAGEC2](../MAGEC2)|2 |
55
+|[MS4A1](../MS4A1)|1 |
56
+|[NFKB2](../NFKB2)|2 |
57
+|[RGS1](../RGS1)|2 |
58
+|[VMP1](../VMP1)|2 |
59 59
60 60
# Details
61 61
papers/muppidiLossSignalingGa132014b.md
... ...
@@ -35,9 +35,9 @@ All other BL studies, BL Tier 2, 155
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ARHGEF1](ARHGEF1)|2 |
39
-|[P2RY8](P2RY8)|1 |
40
-|[S1PR2](S1PR2)|2 |
38
+|[ARHGEF1](../ARHGEF1)|2 |
39
+|[P2RY8](../P2RY8)|1 |
40
+|[S1PR2](../S1PR2)|2 |
41 41
42 42
# Details
43 43
papers/nadeuGenomicEpigenomicInsights2020b.md
... ...
@@ -35,11 +35,11 @@ All other MCL studies, MCL Tier 2, 44
35 35
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38
-|[BCOR](BCOR)|2 |
39
-|[SMARCA4](SMARCA4)|1 |
40
-|[SMARCB1](SMARCB1)|2 |
41
-|[SYNE1](SYNE1)|1 |
42
-|[TERT](TERT)|1 |
38
+|[BCOR](../BCOR)|2 |
39
+|[SMARCA4](../SMARCA4)|1 |
40
+|[SMARCB1](../SMARCB1)|2 |
41
+|[SYNE1](../SYNE1)|1 |
42
+|[TERT](../TERT)|1 |
43 43
44 44
# Details
45 45
papers/ngoOncogenicallyActiveMYD882011a.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[MYD88](MYD88)|1 |
38
+|[MYD88](../MYD88)|1 |
39 39
40 40
# Details
41 41
papers/ohgamiSTAT3MutationsAre2014.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[STAT3](STAT3)|1 |
38
+|[STAT3](../STAT3)|1 |
39 39
40 40
# Details
41 41
papers/okosunRecurrentMTORC1activatingRRAGC2016a.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|DLBCL|1|0|
12 11
|FL|3|0|
12
+|DLBCL|1|0|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -34,11 +34,11 @@ All other FL studies, FL Tier 2, 50
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|DLBCL tier|FL tier|
37
+|New gene|FL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[ATP6AP1](ATP6AP1)| |1 |
40
-|[ATP6V1B2](ATP6V1B2)| |1 |
41
-|[RRAGC](RRAGC)|1 |1 |
39
+|[ATP6AP1](../ATP6AP1)|1 | |
40
+|[ATP6V1B2](../ATP6V1B2)|1 | |
41
+|[RRAGC](../RRAGC)|1 |1 |
42 42
43 43
# Details
44 44
papers/oricchioGeneticEpigeneticInactivation2017b.md
... ...
@@ -35,7 +35,7 @@ All other FL studies, FL Tier 2, 49
35 35
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38
-|[SESN1](SESN1)|2 |
38
+|[SESN1](../SESN1)|2 |
39 39
40 40
# Details
41 41
papers/ottoGeneticLesionsTRAF32012a.md
... ...
@@ -35,8 +35,8 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[MAP3K14](MAP3K14)|1 |
39
-|[TRAF3](TRAF3)|1 |
38
+|[MAP3K14](../MAP3K14)|1 |
39
+|[TRAF3](../TRAF3)|1 |
40 40
41 41
# Details
42 42
papers/paneaWholeGenomeLandscape2019.md
... ...
@@ -35,56 +35,56 @@ All other BL studies, BL Tier 2, 111
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[ALPK2](ALPK2)|2 |
39
-|[BMP7](BMP7)|1 |
40
-|[CARD11](CARD11)|2 |
41
-|[CD79B](CD79B)|2 |
42
-|[CD83](CD83)|2 |
43
-|[CTCF](CTCF)|2 |
44
-|[CXCR4](CXCR4)|2 |
45
-|[DNMT1](DNMT1)|2 |
46
-|[DTX1](DTX1)|2 |
47
-|[EIF4A1](EIF4A1)|1 |
48
-|[EP300](EP300)|2 |
49
-|[EPPK1](EPPK1)|1 |
50
-|[ETS1](ETS1)|2 |
51
-|[FZD3](FZD3)|2 |
52
-|[GRB2](GRB2)|2 |
53
-|[HIST1H1C](HIST1H1C)|2 |
54
-|[HIST1H2AG](HIST1H2AG)|2 |
55
-|[HIST1H2AM](HIST1H2AM)|2 |
56
-|[HIST1H2BK](HIST1H2BK)|2 |
57
-|[HIST1H3D](HIST1H3D)|2 |
58
-|[HIST1H3H](HIST1H3H)|2 |
59
-|[HIST1H3I](HIST1H3I)|2 |
60
-|[HIST1H3J](HIST1H3J)|2 |
61
-|[HIST1H4J](HIST1H4J)|2 |
62
-|[HNRNPU](HNRNPU)|1 |
63
-|[IGLL5](IGLL5)|2 |
64
-|[IKZF3](IKZF3)|2 |
65
-|[IRF8](IRF8)|2 |
66
-|[KCNK10](KCNK10)|2 |
67
-|[KLHL6](KLHL6)|2 |
68
-|[LTB](LTB)|2 |
69
-|[MCL1](MCL1)|2 |
70
-|[MME](MME)|2 |
71
-|[MTOR](MTOR)|2 |
72
-|[NOTCH2](NOTCH2)|2 |
73
-|[PABPC4L](PABPC4L)|2 |
74
-|[PCDHA11](PCDHA11)|2 |
75
-|[PDZRN3](PDZRN3)|2 |
76
-|[PIK3R1](PIK3R1)|2 |
77
-|[PLCG2](PLCG2)|2 |
78
-|[PXDNL](PXDNL)|2 |
79
-|[RAC2](RAC2)|2 |
80
-|[RNF144B](RNF144B)|2 |
81
-|[SNTB2](SNTB2)|2 |
82
-|[SP3](SP3)|2 |
83
-|[SYNCRIP](SYNCRIP)|2 |
84
-|[TET2](TET2)|2 |
85
-|[WDR7](WDR7)|2 |
86
-|[WNK2](WNK2)|2 |
87
-|[ZFP36L1](ZFP36L1)|2 |
38
+|[ALPK2](../ALPK2)|2 |
39
+|[BMP7](../BMP7)|1 |
40
+|[CARD11](../CARD11)|2 |
41
+|[CD79B](../CD79B)|2 |
42
+|[CD83](../CD83)|2 |
43
+|[CTCF](../CTCF)|2 |
44
+|[CXCR4](../CXCR4)|2 |
45
+|[DNMT1](../DNMT1)|2 |
46
+|[DTX1](../DTX1)|2 |
47
+|[EIF4A1](../EIF4A1)|1 |
48
+|[EP300](../EP300)|2 |
49
+|[EPPK1](../EPPK1)|1 |
50
+|[ETS1](../ETS1)|2 |
51
+|[FZD3](../FZD3)|2 |
52
+|[GRB2](../GRB2)|2 |
53
+|[HIST1H1C](../HIST1H1C)|2 |
54
+|[HIST1H2AG](../HIST1H2AG)|2 |
55
+|[HIST1H2AM](../HIST1H2AM)|2 |
56
+|[HIST1H2BK](../HIST1H2BK)|2 |
57
+|[HIST1H3D](../HIST1H3D)|2 |
58
+|[HIST1H3H](../HIST1H3H)|2 |
59
+|[HIST1H3I](../HIST1H3I)|2 |
60
+|[HIST1H3J](../HIST1H3J)|2 |
61
+|[HIST1H4J](../HIST1H4J)|2 |
62
+|[HNRNPU](../HNRNPU)|1 |
63
+|[IGLL5](../IGLL5)|2 |
64
+|[IKZF3](../IKZF3)|2 |
65
+|[IRF8](../IRF8)|2 |
66
+|[KCNK10](../KCNK10)|2 |
67
+|[KLHL6](../KLHL6)|2 |
68
+|[LTB](../LTB)|2 |
69
+|[MCL1](../MCL1)|2 |
70
+|[MME](../MME)|2 |
71
+|[MTOR](../MTOR)|2 |
72
+|[NOTCH2](../NOTCH2)|2 |
73
+|[PABPC4L](../PABPC4L)|2 |
74
+|[PCDHA11](../PCDHA11)|2 |
75
+|[PDZRN3](../PDZRN3)|2 |
76
+|[PIK3R1](../PIK3R1)|2 |
77
+|[PLCG2](../PLCG2)|2 |
78
+|[PXDNL](../PXDNL)|2 |
79
+|[RAC2](../RAC2)|2 |
80
+|[RNF144B](../RNF144B)|2 |
81
+|[SNTB2](../SNTB2)|2 |
82
+|[SP3](../SP3)|2 |
83
+|[SYNCRIP](../SYNCRIP)|2 |
84
+|[TET2](../TET2)|2 |
85
+|[WDR7](../WDR7)|2 |
86
+|[WNK2](../WNK2)|2 |
87
+|[ZFP36L1](../ZFP36L1)|2 |
88 88
89 89
# Details
90 90
papers/pararajalingamCodingNoncodingDrivers2020.md
... ...
@@ -36,13 +36,13 @@ All other MCL studies, MCL Tier 2, 45
36 36
37 37
|New gene|DLBCL tier|MCL tier|
38 38
|:-|:-:|:-:|
39
-|[B2M](B2M)|1 |2 |
40
-|[DAZAP1](DAZAP1)|2 |1 |
41
-|[EWSR1](EWSR1)| |1 |
42
-|[HNRNPH1](HNRNPH1)|2 |1 |
43
-|[NFKBIE](NFKBIE)|1 |1 |
44
-|[S1PR1](S1PR1)| |1 |
45
-|[UBR5](UBR5)|2 |1 |
39
+|[B2M](../B2M)|1 |2 |
40
+|[DAZAP1](../DAZAP1)|2 |1 |
41
+|[EWSR1](../EWSR1)| |1 |
42
+|[HNRNPH1](../HNRNPH1)|2 |1 |
43
+|[NFKBIE](../NFKBIE)|1 |1 |
44
+|[S1PR1](../S1PR1)| |1 |
45
+|[UBR5](../UBR5)|2 |1 |
46 46
47 47
# Details
48 48
papers/parryWholeExomeSequencing2013.md
... ...
@@ -36,14 +36,14 @@ All other MZL studies, MZL Tier 2, 66
36 36
37 37
|New gene|MZL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[AMOTL1](AMOTL1)|2 | |
40
-|[CBFA2T3](CBFA2T3)|2 | |
41
-|[CREBBP](CREBBP)|2 |1 |
42
-|[FAT4](FAT4)|2 |2 |
43
-|[FBXO11](FBXO11)|2 |1 |
44
-|[PLA2G4D](PLA2G4D)|2 | |
45
-|[TRRAP](TRRAP)|2 |1 |
46
-|[USH2A](USH2A)|2 | |
39
+|[AMOTL1](../AMOTL1)|2 | |
40
+|[CBFA2T3](../CBFA2T3)|2 | |
41
+|[CREBBP](../CREBBP)|2 |1 |
42
+|[FAT4](../FAT4)|2 |2 |
43
+|[FBXO11](../FBXO11)|2 |1 |
44
+|[PLA2G4D](../PLA2G4D)|2 | |
45
+|[TRRAP](../TRRAP)|2 |1 |
46
+|[USH2A](../USH2A)|2 | |
47 47
48 48
# Details
49 49
papers/pasqualucciAnalysisCodingGenome2011.md
... ...
@@ -35,13 +35,13 @@ All other DLBCL studies, DLBCL Tier 2, 194
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CD36](CD36)|2 |
39
-|[GRB2](GRB2)|1 |
40
-|[HNF1B](HNF1B)|2 |
41
-|[KLF2](KLF2)|1 |
42
-|[MYOM2](MYOM2)|2 |
43
-|[NOTCH1](NOTCH1)|1 |
44
-|[TRAF3](TRAF3)|2 |
38
+|[CD36](../CD36)|2 |
39
+|[GRB2](../GRB2)|1 |
40
+|[HNF1B](../HNF1B)|2 |
41
+|[KLF2](../KLF2)|1 |
42
+|[MYOM2](../MYOM2)|2 |
43
+|[NOTCH1](../NOTCH1)|1 |
44
+|[TRAF3](../TRAF3)|2 |
45 45
46 46
# Details
47 47
papers/pasqualucciHypermutationMultipleProtooncogenes2001a.md
... ...
@@ -35,10 +35,10 @@ All other DLBCL studies, DLBCL Tier 2, 196
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[MYC](MYC)|1 |
39
-|[PAX5](PAX5)|2 |
40
-|[PIM1](PIM1)|1 |
41
-|[RHOH](RHOH)|2 |
38
+|[MYC](../MYC)|1 |
39
+|[PAX5](../PAX5)|2 |
40
+|[PIM1](../PIM1)|1 |
41
+|[RHOH](../RHOH)|2 |
42 42
43 43
# Details
44 44
papers/pasqualucciInactivatingMutationsAcetyltransferase2011a.md
... ...
@@ -36,8 +36,8 @@ All other FL studies, FL Tier 2, 50
36 36
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[CREBBP](CREBBP)|1 |1 |
40
-|[EP300](EP300)|1 |1 |
39
+|[CREBBP](../CREBBP)|1 |1 |
40
+|[EP300](../EP300)|1 |1 |
41 41
42 42
# Details
43 43
papers/pasqualucciInactivationPRDM1BLIMP12006a.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[PRDM1](PRDM1)|1 |
38
+|[PRDM1](../PRDM1)|1 |
39 39
40 40
# Details
41 41
papers/reddyGeneticFunctionalDrivers2017.md
... ...
@@ -35,66 +35,66 @@ All other DLBCL studies, DLBCL Tier 2, 145
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[ANKRD17](ANKRD17)|2 |
39
-|[ARID1B](ARID1B)|2 |
40
-|[ARID5B](ARID5B)|2 |
41
-|[ATM](ATM)|1 |
42
-|[ATR](ATR)|2 |
43
-|[BIRC6](BIRC6)|1 |
44
-|[BRINP3](BRINP3)|2 |
45
-|[BTBD3](BTBD3)|2 |
46
-|[CASP8](CASP8)|2 |
47
-|[CBLB](CBLB)|2 |
48
-|[CD22](CD22)|2 |
49
-|[CDC73](CDC73)|2 |
50
-|[CHD1](CHD1)|2 |
51
-|[CHD8](CHD8)|2 |
52
-|[CHST2](CHST2)|2 |
53
-|[DCAF6](DCAF6)|2 |
54
-|[DDX10](DDX10)|2 |
55
-|[DICER1](DICER1)|2 |
56
-|[DNMT3A](DNMT3A)|2 |
57
-|[FOXP1](FOXP1)|2 |
58
-|[FUBP1](FUBP1)|2 |
59
-|[GNAS](GNAS)|2 |
60
-|[GOLGA5](GOLGA5)|2 |
61
-|[HIST1H2BC](HIST1H2BC)|1 |
62
-|[HNRNPU](HNRNPU)|1 |
63
-|[HRAS](HRAS)|2 |
64
-|[IKBKB](IKBKB)|2 |
65
-|[JUNB](JUNB)|2 |
66
-|[KCMF1](KCMF1)|2 |
67
-|[LIN54](LIN54)|2 |
68
-|[MAGT1](MAGT1)|2 |
69
-|[MAP4K4](MAP4K4)|2 |
70
-|[MARK1](MARK1)|2 |
71
-|[MCL1](MCL1)|2 |
72
-|[MECOM](MECOM)|2 |
73
-|[MET](MET)|2 |
74
-|[MSH2](MSH2)|2 |
75
-|[MSH6](MSH6)|2 |
76
-|[MYB](MYB)|2 |
77
-|[NCOR1](NCOR1)|2 |
78
-|[NF1](NF1)|2 |
79
-|[NFKB2](NFKB2)|2 |
80
-|[PHF6](PHF6)|2 |
81
-|[PIK3CD](PIK3CD)|2 |
82
-|[PTPN6](PTPN6)|2 |
83
-|[PTPRK](PTPRK)|2 |
84
-|[RARA](RARA)|2 |
85
-|[RUNX1](RUNX1)|2 |
86
-|[SETD1B](SETD1B)|1 |
87
-|[SETD5](SETD5)|2 |
88
-|[SYK](SYK)|2 |
89
-|[TGFBR2](TGFBR2)|2 |
90
-|[TIPARP](TIPARP)|2 |
91
-|[TOX](TOX)|1 |
92
-|[UBE2A](UBE2A)|1 |
93
-|[WAC](WAC)|2 |
94
-|[YY1](YY1)|2 |
95
-|[ZBTB7A](ZBTB7A)|2 |
96
-|[ZFAT](ZFAT)|2 |
97
-|[ZFX](ZFX)|2 |
38
+|[ANKRD17](../ANKRD17)|2 |
39
+|[ARID1B](../ARID1B)|2 |
40
+|[ARID5B](../ARID5B)|2 |
41
+|[ATM](../ATM)|1 |
42
+|[ATR](../ATR)|2 |
43
+|[BIRC6](../BIRC6)|1 |
44
+|[BRINP3](../BRINP3)|2 |
45
+|[BTBD3](../BTBD3)|2 |
46
+|[CASP8](../CASP8)|2 |
47
+|[CBLB](../CBLB)|2 |
48
+|[CD22](../CD22)|2 |
49
+|[CDC73](../CDC73)|2 |
50
+|[CHD1](../CHD1)|2 |
51
+|[CHD8](../CHD8)|2 |
52
+|[CHST2](../CHST2)|2 |
53
+|[DCAF6](../DCAF6)|2 |
54
+|[DDX10](../DDX10)|2 |
55
+|[DICER1](../DICER1)|2 |
56
+|[DNMT3A](../DNMT3A)|2 |
57
+|[FOXP1](../FOXP1)|2 |
58
+|[FUBP1](../FUBP1)|2 |
59
+|[GNAS](../GNAS)|2 |
60
+|[GOLGA5](../GOLGA5)|2 |
61
+|[HIST1H2BC](../HIST1H2BC)|1 |
62
+|[HNRNPU](../HNRNPU)|1 |
63
+|[HRAS](../HRAS)|2 |
64
+|[IKBKB](../IKBKB)|2 |
65
+|[JUNB](../JUNB)|2 |
66
+|[KCMF1](../KCMF1)|2 |
67
+|[LIN54](../LIN54)|2 |
68
+|[MAGT1](../MAGT1)|2 |
69
+|[MAP4K4](../MAP4K4)|2 |
70
+|[MARK1](../MARK1)|2 |
71
+|[MCL1](../MCL1)|2 |
72
+|[MECOM](../MECOM)|2 |
73
+|[MET](../MET)|2 |
74
+|[MSH2](../MSH2)|2 |
75
+|[MSH6](../MSH6)|2 |
76
+|[MYB](../MYB)|2 |
77
+|[NCOR1](../NCOR1)|2 |
78
+|[NF1](../NF1)|2 |
79
+|[NFKB2](../NFKB2)|2 |
80
+|[PHF6](../PHF6)|2 |
81
+|[PIK3CD](../PIK3CD)|2 |
82
+|[PTPN6](../PTPN6)|2 |
83
+|[PTPRK](../PTPRK)|2 |
84
+|[RARA](../RARA)|2 |
85
+|[RUNX1](../RUNX1)|2 |
86
+|[SETD1B](../SETD1B)|1 |
87
+|[SETD5](../SETD5)|2 |
88
+|[SYK](../SYK)|2 |
89
+|[TGFBR2](../TGFBR2)|2 |
90
+|[TIPARP](../TIPARP)|2 |
91
+|[TOX](../TOX)|1 |
92
+|[UBE2A](../UBE2A)|1 |
93
+|[WAC](../WAC)|2 |
94
+|[YY1](../YY1)|2 |
95
+|[ZBTB7A](../ZBTB7A)|2 |
96
+|[ZFAT](../ZFAT)|2 |
97
+|[ZFX](../ZFX)|2 |
98 98
99 99
# Details
100 100
papers/reichelFlowSortingExome2015a.md
... ...
@@ -35,35 +35,35 @@ All other PMBL studies, PMBL Tier 2, 64
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ARIH2](ARIH2)|2 |
39
-|[B2M](B2M)|1 |
40
-|[BCL7A](BCL7A)|2 |
41
-|[CSF2RB](CSF2RB)|1 |
42
-|[DMD](DMD)|2 |
43
-|[EBF1](EBF1)|1 |
44
-|[EEF1A1](EEF1A1)|1 |
45
-|[EGR1](EGR1)|2 |
46
-|[GNA13](GNA13)|1 |
47
-|[HECW2](HECW2)|2 |
48
-|[HELLS](HELLS)|2 |
49
-|[HIST1H1E](HIST1H1E)|1 |
50
-|[HIST1H3B](HIST1H3B)|2 |
51
-|[HIST1H4C](HIST1H4C)|2 |
52
-|[ITPKB](ITPKB)|1 |
53
-|[MPDZ](MPDZ)|2 |
54
-|[NEK1](NEK1)|2 |
55
-|[PIM2](PIM2)|1 |
56
-|[RANBP2](RANBP2)|2 |
57
-|[SENP7](SENP7)|2 |
58
-|[SETDB1](SETDB1)|2 |
59
-|[SIAH2](SIAH2)|2 |
60
-|[TBC1D15](TBC1D15)|2 |
61
-|[TICRR](TICRR)|2 |
62
-|[TRIP11](TRIP11)|2 |
63
-|[UBE2A](UBE2A)|1 |
64
-|[WEE1](WEE1)|1 |
65
-|[ZFP36L1](ZFP36L1)|1 |
66
-|[ZNF217](ZNF217)|2 |
38
+|[ARIH2](../ARIH2)|2 |
39
+|[B2M](../B2M)|1 |
40
+|[BCL7A](../BCL7A)|2 |
41
+|[CSF2RB](../CSF2RB)|1 |
42
+|[DMD](../DMD)|2 |
43
+|[EBF1](../EBF1)|1 |
44
+|[EEF1A1](../EEF1A1)|1 |
45
+|[EGR1](../EGR1)|2 |
46
+|[GNA13](../GNA13)|1 |
47
+|[HECW2](../HECW2)|2 |
48
+|[HELLS](../HELLS)|2 |
49
+|[HIST1H1E](../HIST1H1E)|1 |
50
+|[HIST1H3B](../HIST1H3B)|2 |
51
+|[HIST1H4C](../HIST1H4C)|2 |
52
+|[ITPKB](../ITPKB)|1 |
53
+|[MPDZ](../MPDZ)|2 |
54
+|[NEK1](../NEK1)|2 |
55
+|[PIM2](../PIM2)|1 |
56
+|[RANBP2](../RANBP2)|2 |
57
+|[SENP7](../SENP7)|2 |
58
+|[SETDB1](../SETDB1)|2 |
59
+|[SIAH2](../SIAH2)|2 |
60
+|[TBC1D15](../TBC1D15)|2 |
61
+|[TICRR](../TICRR)|2 |
62
+|[TRIP11](../TRIP11)|2 |
63
+|[UBE2A](../UBE2A)|1 |
64
+|[WEE1](../WEE1)|1 |
65
+|[ZFP36L1](../ZFP36L1)|1 |
66
+|[ZNF217](../ZNF217)|2 |
67 67
68 68
# Details
69 69
papers/richterRecurrentMutationID32012a.md
... ...
@@ -35,11 +35,11 @@ All other BL studies, BL Tier 2, 157
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[CCND3](CCND3)|1 |
39
-|[FBXO11](FBXO11)|1 |
40
-|[ID3](ID3)|1 |
41
-|[RHOA](RHOA)|1 |
42
-|[SMARCA4](SMARCA4)|1 |
38
+|[CCND3](../CCND3)|1 |
39
+|[FBXO11](../FBXO11)|1 |
40
+|[ID3](../ID3)|1 |
41
+|[RHOA](../RHOA)|1 |
42
+|[SMARCA4](../SMARCA4)|1 |
43 43
44 44
# Details
45 45
papers/ritzRecurrentMutationsSTAT62009a.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[STAT6](STAT6)|1 |
38
+|[STAT6](../STAT6)|1 |
39 39
40 40
# Details
41 41
papers/rossiAlterationBIRC3Multiple2011a.md
... ...
@@ -35,11 +35,11 @@ All other MZL studies, MZL Tier 2, 73
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[BIRC3](BIRC3)|1 |
39
-|[IKBKB](IKBKB)|2 |
40
-|[MAP3K14](MAP3K14)|1 |
41
-|[TNFAIP3](TNFAIP3)|1 |
42
-|[TRAF3](TRAF3)|1 |
38
+|[BIRC3](../BIRC3)|1 |
39
+|[IKBKB](../IKBKB)|2 |
40
+|[MAP3K14](../MAP3K14)|1 |
41
+|[TNFAIP3](../TNFAIP3)|1 |
42
+|[TRAF3](../TRAF3)|1 |
43 43
44 44
# Details
45 45
papers/rossiCodingGenomeSplenic2012c.md
... ...
@@ -8,8 +8,8 @@ bibliography: 'morinlab.bib'
8 8
9 9
|Entity| Tier 1 genes| Tier 2 genes|
10 10
|:-:|:-:|:-:|
11
-|MZL|10|11|
12 11
|DLBCL|12|2|
12
+|MZL|10|11|
13 13
```mermaid
14 14
---
15 15
config:
... ...
@@ -34,29 +34,29 @@ All other MZL studies, MZL Tier 2, 63
34 34
35 35
## Novel genes reported in this study
36 36
37
-|New gene|MZL tier|DLBCL tier|
37
+|New gene|DLBCL tier|MZL tier|
38 38
|:-|:-:|:-:|
39
-|[ARID1A](ARID1A)|1 |1 |
40
-|[CD79A](CD79A)|2 | |
41
-|[DTX1](DTX1)|1 |1 |
42
-|[EGR1](EGR1)|2 | |
43
-|[EGR2](EGR2)|2 | |
44
-|[EP300](EP300)|1 |1 |
45
-|[GPS2](GPS2)|2 | |
46
-|[HIST1H2AG](HIST1H2AG)|2 |2 |
47
-|[HIST1H2BK](HIST1H2BK)|2 |1 |
48
-|[KMT2D](KMT2D)|1 |1 |
49
-|[MCRS1](MCRS1)|2 | |
50
-|[MSL2](MSL2)|2 | |
51
-|[NOTCH1](NOTCH1)|1 |1 |
52
-|[NOTCH2](NOTCH2)|1 |1 |
53
-|[SIN3A](SIN3A)|1 |1 |
54
-|[SPEN](SPEN)|1 |1 |
55
-|[SWAP70](SWAP70)|2 | |
56
-|[TBL1XR1](TBL1XR1)|1 |1 |
57
-|[TP53](TP53)|1 |1 |
58
-|[TRRAP](TRRAP)|2 |1 |
59
-|[WAC](WAC)|2 |2 |
39
+|[ARID1A](../ARID1A)|1 |1 |
40
+|[CD79A](../CD79A)| |2 |
41
+|[DTX1](../DTX1)|1 |1 |
42
+|[EGR1](../EGR1)| |2 |
43
+|[EGR2](../EGR2)| |2 |
44
+|[EP300](../EP300)|1 |1 |
45
+|[GPS2](../GPS2)| |2 |
46
+|[HIST1H2AG](../HIST1H2AG)|2 |2 |
47
+|[HIST1H2BK](../HIST1H2BK)|1 |2 |
48
+|[KMT2D](../KMT2D)|1 |1 |
49
+|[MCRS1](../MCRS1)| |2 |
50
+|[MSL2](../MSL2)| |2 |
51
+|[NOTCH1](../NOTCH1)|1 |1 |
52
+|[NOTCH2](../NOTCH2)|1 |1 |
53
+|[SIN3A](../SIN3A)|1 |1 |
54
+|[SPEN](../SPEN)|1 |1 |
55
+|[SWAP70](../SWAP70)| |2 |
56
+|[TBL1XR1](../TBL1XR1)|1 |1 |
57
+|[TP53](../TP53)|1 |1 |
58
+|[TRRAP](../TRRAP)|1 |2 |
59
+|[WAC](../WAC)|2 |2 |
60 60
61 61
# Details
62 62
papers/rushtonGeneticEvolutionaryPatterns2020.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[MS4A1](MS4A1)|1 |
38
+|[MS4A1](../MS4A1)|1 |
39 39
40 40
# Details
41 41
papers/russler-germainMutationsAssociatedProgression2023b.md
... ...
@@ -35,26 +35,26 @@ All other FL studies, FL Tier 2, 31
35 35
36 36
|New gene|FL tier|
37 37
|:-|:-:|
38
-|[ABL2](ABL2)|2 |
39
-|[BCL10](BCL10)|2 |
40
-|[CD70](CD70)|2 |
41
-|[CD83](CD83)|1 |
42
-|[CILP](CILP)|2 |
43
-|[CYP2A6](CYP2A6)|2 |
44
-|[GBP7](GBP7)|2 |
45
-|[GRM6](GRM6)|2 |
46
-|[IGLL5](IGLL5)|2 |
47
-|[KIR3DL1](KIR3DL1)|2 |
48
-|[MAGEC1](MAGEC1)|2 |
49
-|[MAP7D1](MAP7D1)|2 |
50
-|[MKI67](MKI67)|2 |
51
-|[NFKBIA](NFKBIA)|2 |
52
-|[OR8H2](OR8H2)|2 |
53
-|[PZP](PZP)|2 |
54
-|[SHROOM3](SHROOM3)|2 |
55
-|[SRRM2](SRRM2)|2 |
56
-|[STAB2](STAB2)|2 |
57
-|[XIRP2](XIRP2)|2 |
38
+|[ABL2](../ABL2)|2 |
39
+|[BCL10](../BCL10)|2 |
40
+|[CD70](../CD70)|2 |
41
+|[CD83](../CD83)|1 |
42
+|[CILP](../CILP)|2 |
43
+|[CYP2A6](../CYP2A6)|2 |
44
+|[GBP7](../GBP7)|2 |
45
+|[GRM6](../GRM6)|2 |
46
+|[IGLL5](../IGLL5)|2 |
47
+|[KIR3DL1](../KIR3DL1)|2 |
48
+|[MAGEC1](../MAGEC1)|2 |
49
+|[MAP7D1](../MAP7D1)|2 |
50
+|[MKI67](../MKI67)|2 |
51
+|[NFKBIA](../NFKBIA)|2 |
52
+|[OR8H2](../OR8H2)|2 |
53
+|[PZP](../PZP)|2 |
54
+|[SHROOM3](../SHROOM3)|2 |
55
+|[SRRM2](../SRRM2)|2 |
56
+|[STAB2](../STAB2)|2 |
57
+|[XIRP2](../XIRP2)|2 |
58 58
59 59
# Details
60 60
papers/sarkozyMutationalLandscapeGray2021a.md
... ...
@@ -35,17 +35,17 @@ All other PMBL studies, PMBL Tier 2, 76
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ABCA13](ABCA13)|2 |
39
-|[BCL2](BCL2)|2 |
40
-|[BIRC6](BIRC6)|1 |
41
-|[BTG1](BTG1)|1 |
42
-|[HIST1H1B](HIST1H1B)|1 |
43
-|[KMT2C](KMT2C)|1 |
44
-|[LRRN3](LRRN3)|2 |
45
-|[MFHAS1](MFHAS1)|2 |
46
-|[NCOR2](NCOR2)|2 |
47
-|[RELN](RELN)|2 |
48
-|[SPEN](SPEN)|1 |
38
+|[ABCA13](../ABCA13)|2 |
39
+|[BCL2](../BCL2)|2 |
40
+|[BIRC6](../BIRC6)|1 |
41
+|[BTG1](../BTG1)|1 |
42
+|[HIST1H1B](../HIST1H1B)|1 |
43
+|[KMT2C](../KMT2C)|1 |
44
+|[LRRN3](../LRRN3)|2 |
45
+|[MFHAS1](../MFHAS1)|2 |
46
+|[NCOR2](../NCOR2)|2 |
47
+|[RELN](../RELN)|2 |
48
+|[SPEN](../SPEN)|1 |
49 49
50 50
# Details
51 51
papers/schmitzBurkittLymphomaPathogenesis2012.md
... ...
@@ -36,26 +36,26 @@ All other BL studies, BL Tier 2, 141
36 36
37 37
|New gene|BL tier|DLBCL tier|
38 38
|:-|:-:|:-:|
39
-|[C16orf48](C16orf48)|2 | |
40
-|[DDX3X](DDX3X)|1 |1 |
41
-|[DHCR7](DHCR7)|2 | |
42
-|[ELP2](ELP2)|2 | |
43
-|[EXOSC6](EXOSC6)|2 | |
44
-|[FLYWCH1](FLYWCH1)|2 | |
45
-|[FOXO1](FOXO1)|1 |1 |
46
-|[GTSE1](GTSE1)|2 | |
47
-|[ID3](ID3)|1 |2 |
48
-|[KANK2](KANK2)|2 | |
49
-|[MKI67](MKI67)|2 | |
50
-|[MYO18A](MYO18A)|2 | |
51
-|[NCOR2](NCOR2)|2 |2 |
52
-|[PCBP1](PCBP1)|2 |2 |
53
-|[PDCD11](PDCD11)|2 | |
54
-|[TCF3](TCF3)|1 | |
55
-|[TOP2A](TOP2A)|2 | |
56
-|[WDR90](WDR90)|2 | |
57
-|[WHAMM](WHAMM)|2 | |
58
-|[YY1AP1](YY1AP1)|2 | |
39
+|[C16orf48](../C16orf48)|2 | |
40
+|[DDX3X](../DDX3X)|1 |1 |
41
+|[DHCR7](../DHCR7)|2 | |
42
+|[ELP2](../ELP2)|2 | |
43
+|[EXOSC6](../EXOSC6)|2 | |
44
+|[FLYWCH1](../FLYWCH1)|2 | |
45
+|[FOXO1](../FOXO1)|1 |1 |
46
+|[GTSE1](../GTSE1)|2 | |
47
+|[ID3](../ID3)|1 |2 |
48
+|[KANK2](../KANK2)|2 | |
49
+|[MKI67](../MKI67)|2 | |
50
+|[MYO18A](../MYO18A)|2 | |
51
+|[NCOR2](../NCOR2)|2 |2 |
52
+|[PCBP1](../PCBP1)|2 |2 |
53
+|[PDCD11](../PDCD11)|2 | |
54
+|[TCF3](../TCF3)|1 | |
55
+|[TOP2A](../TOP2A)|2 | |
56
+|[WDR90](../WDR90)|2 | |
57
+|[WHAMM](../WHAMM)|2 | |
58
+|[YY1AP1](../YY1AP1)|2 | |
59 59
60 60
# Details
61 61
papers/schmitzGeneticsPathogenesisDiffuse2018a.md
... ...
@@ -35,22 +35,22 @@ All other DLBCL studies, DLBCL Tier 2, 189
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[CXCR5](CXCR5)|1 |
39
-|[DDX3X](DDX3X)|1 |
40
-|[DTX1](DTX1)|1 |
41
-|[FOXC1](FOXC1)|2 |
42
-|[GPC5](GPC5)|2 |
43
-|[GSG2](GSG2)|2 |
44
-|[HIST2H2BE](HIST2H2BE)|1 |
45
-|[ITPKB](ITPKB)|1 |
46
-|[KLHL21](KLHL21)|2 |
47
-|[LAMA5](LAMA5)|2 |
48
-|[MYBPC2](MYBPC2)|2 |
49
-|[NOL9](NOL9)|1 |
50
-|[PAPOLG](PAPOLG)|2 |
51
-|[PRKDC](PRKDC)|2 |
52
-|[TAP1](TAP1)|2 |
53
-|[WEE1](WEE1)|1 |
38
+|[CXCR5](../CXCR5)|1 |
39
+|[DDX3X](../DDX3X)|1 |
40
+|[DTX1](../DTX1)|1 |
41
+|[FOXC1](../FOXC1)|2 |
42
+|[GPC5](../GPC5)|2 |
43
+|[GSG2](../GSG2)|2 |
44
+|[HIST2H2BE](../HIST2H2BE)|1 |
45
+|[ITPKB](../ITPKB)|1 |
46
+|[KLHL21](../KLHL21)|2 |
47
+|[LAMA5](../LAMA5)|2 |
48
+|[MYBPC2](../MYBPC2)|2 |
49
+|[NOL9](../NOL9)|1 |
50
+|[PAPOLG](../PAPOLG)|2 |
51
+|[PRKDC](../PRKDC)|2 |
52
+|[TAP1](../TAP1)|2 |
53
+|[WEE1](../WEE1)|1 |
54 54
55 55
# Details
56 56
papers/schmitzTNFAIP3A20Tumor2009a.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[TNFAIP3](TNFAIP3)|1 |
38
+|[TNFAIP3](../TNFAIP3)|1 |
39 39
40 40
# Details
41 41
papers/schneiderAlterationsCD58Gene2015a.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[CD58](CD58)|1 |
38
+|[CD58](../CD58)|1 |
39 39
40 40
# Details
41 41
papers/schollMutationsRegionFAS2007.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[FAS](FAS)|1 |
38
+|[FAS](../FAS)|1 |
39 39
40 40
# Details
41 41
papers/shinBRAFV600EMAP2K12015.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 197
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[MAP2K1](MAP2K1)|2 |
38
+|[MAP2K1](../MAP2K1)|2 |
39 39
40 40
# Details
41 41
papers/spinaGeneticsNodalMarginal2016b.md
... ...
@@ -35,37 +35,37 @@ All other MZL studies, MZL Tier 2, 51
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[ABCA13](ABCA13)|2 |
39
-|[ACTG1](ACTG1)|2 |
40
-|[ADD2](ADD2)|2 |
41
-|[AMN](AMN)|2 |
42
-|[AOC2](AOC2)|2 |
43
-|[BCL10](BCL10)|1 |
44
-|[C6orf103](C6orf103)|2 |
45
-|[CDC42BPB](CDC42BPB)|2 |
46
-|[CDKN2A](CDKN2A)|2 |
47
-|[CLGN](CLGN)|2 |
48
-|[CNKSR2](CNKSR2)|2 |
49
-|[FAS](FAS)|1 |
50
-|[FAT1](FAT1)|1 |
51
-|[GPR98](GPR98)|2 |
52
-|[ID3](ID3)|1 |
53
-|[LRP1B](LRP1B)|2 |
54
-|[NCOR2](NCOR2)|1 |
55
-|[NOL9](NOL9)|1 |
56
-|[PACRG](PACRG)|2 |
57
-|[PARK2](PARK2)|2 |
58
-|[PLXNB3](PLXNB3)|2 |
59
-|[PTPRD](PTPRD)|1 |
60
-|[RCOR1](RCOR1)|2 |
61
-|[RPL1L](RPL1L)|2 |
62
-|[SAMD5](SAMD5)|2 |
63
-|[SCG3](SCG3)|2 |
64
-|[STXBP5](STXBP5)|2 |
65
-|[TAF1](TAF1)|2 |
66
-|[TCTN2](TCTN2)|2 |
67
-|[TNFRSF14](TNFRSF14)|1 |
68
-|[ZNF9](ZNF9)|2 |
38
+|[ABCA13](../ABCA13)|2 |
39
+|[ACTG1](../ACTG1)|2 |
40
+|[ADD2](../ADD2)|2 |
41
+|[AMN](../AMN)|2 |
42
+|[AOC2](../AOC2)|2 |
43
+|[BCL10](../BCL10)|1 |
44
+|[C6orf103](../C6orf103)|2 |
45
+|[CDC42BPB](../CDC42BPB)|2 |
46
+|[CDKN2A](../CDKN2A)|2 |
47
+|[CLGN](../CLGN)|2 |
48
+|[CNKSR2](../CNKSR2)|2 |
49
+|[FAS](../FAS)|1 |
50
+|[FAT1](../FAT1)|1 |
51
+|[GPR98](../GPR98)|2 |
52
+|[ID3](../ID3)|1 |
53
+|[LRP1B](../LRP1B)|2 |
54
+|[NCOR2](../NCOR2)|1 |
55
+|[NOL9](../NOL9)|1 |
56
+|[PACRG](../PACRG)|2 |
57
+|[PARK2](../PARK2)|2 |
58
+|[PLXNB3](../PLXNB3)|2 |
59
+|[PTPRD](../PTPRD)|1 |
60
+|[RCOR1](../RCOR1)|2 |
61
+|[RPL1L](../RPL1L)|2 |
62
+|[SAMD5](../SAMD5)|2 |
63
+|[SCG3](../SCG3)|2 |
64
+|[STXBP5](../STXBP5)|2 |
65
+|[TAF1](../TAF1)|2 |
66
+|[TCTN2](../TCTN2)|2 |
67
+|[TNFRSF14](../TNFRSF14)|1 |
68
+|[ZNF9](../ZNF9)|2 |
69 69
70 70
# Details
71 71
papers/tanakaFrequentIncidenceSomatic1992.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[BCL2](BCL2)|1 |
38
+|[BCL2](../BCL2)|1 |
39 39
40 40
# Details
41 41
papers/thomasGeneticSubgroupsInform2023.md
... ...
@@ -35,11 +35,11 @@ All other BL studies, BL Tier 2, 154
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[CDKN2C](CDKN2C)|2 |
39
-|[EBF1](EBF1)|2 |
40
-|[EHD1](EHD1)|2 |
41
-|[PHF6](PHF6)|1 |
42
-|[WNK1](WNK1)|1 |
38
+|[CDKN2C](../CDKN2C)|2 |
39
+|[EBF1](../EBF1)|2 |
40
+|[EHD1](../EHD1)|2 |
41
+|[PHF6](../PHF6)|1 |
42
+|[WNK1](../WNK1)|1 |
43 43
44 44
# Details
45 45
papers/tiacciBRAFMutationsHairycell2011a.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[BRAF](BRAF)|1 |
38
+|[BRAF](../BRAF)|1 |
39 39
40 40
# Details
41 41
papers/tiacciPervasiveMutationsJAKSTAT2018b.md
... ...
@@ -35,16 +35,16 @@ All other PMBL studies, PMBL Tier 2, 73
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[AKAP6](AKAP6)|2 |
39
-|[DGKB](DGKB)|2 |
40
-|[ITPR3](ITPR3)|2 |
41
-|[NUP214](NUP214)|2 |
42
-|[PRUNE2](PRUNE2)|2 |
43
-|[SETD5](SETD5)|2 |
44
-|[STAT5B](STAT5B)|2 |
45
-|[TNIP1](TNIP1)|2 |
46
-|[TP53](TP53)|1 |
47
-|[ZCCHC11](ZCCHC11)|2 |
38
+|[AKAP6](../AKAP6)|2 |
39
+|[DGKB](../DGKB)|2 |
40
+|[ITPR3](../ITPR3)|2 |
41
+|[NUP214](../NUP214)|2 |
42
+|[PRUNE2](../PRUNE2)|2 |
43
+|[SETD5](../SETD5)|2 |
44
+|[STAT5B](../STAT5B)|2 |
45
+|[TNIP1](../TNIP1)|2 |
46
+|[TP53](../TP53)|1 |
47
+|[ZCCHC11](../ZCCHC11)|2 |
48 48
49 49
# Details
50 50
papers/troenNOTCH2MutationsMarginal2008.md
... ...
@@ -35,7 +35,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[NOTCH2](NOTCH2)|1 |
38
+|[NOTCH2](../NOTCH2)|1 |
39 39
40 40
# Details
41 41
papers/vandenbrandRecurrentMutationsGenes2017.md
... ...
@@ -35,8 +35,8 @@ All other MZL studies, MZL Tier 2, 72
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[CD9B](CD9B)|2 |
39
-|[TNIP2](TNIP2)|2 |
38
+|[CD9B](../CD9B)|2 |
39
+|[TNIP2](../TNIP2)|2 |
40 40
41 41
# Details
42 42
papers/viganoSomaticIL4RMutations2018b.md
... ...
@@ -35,7 +35,7 @@ All other PMBL studies, PMBL Tier 2, 82
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[IL4R](IL4R)|1 |
38
+|[IL4R](../IL4R)|1 |
39 39
40 40
# Details
41 41
papers/wenigerMutationsTumorSuppressor2006a.md
... ...
@@ -35,8 +35,8 @@ All other PMBL studies, PMBL Tier 2, 81
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[GPR126](GPR126)|2 |
39
-|[SOCS1](SOCS1)|1 |
38
+|[GPR126](../GPR126)|2 |
39
+|[SOCS1](../SOCS1)|1 |
40 40
41 41
# Details
42 42
papers/wienandGenomicAnalysesFlowsorted2019b.md
... ...
@@ -35,13 +35,13 @@ All other PMBL studies, PMBL Tier 2, 79
35 35
36 36
|New gene|PMBL tier|
37 37
|:-|:-:|
38
-|[ACTB](ACTB)|1 |
39
-|[ARID1A](ARID1A)|1 |
40
-|[DNAH12](DNAH12)|2 |
41
-|[HLA-B](HLA-B)|1 |
42
-|[IKBKB](IKBKB)|2 |
43
-|[NFKBIA](NFKBIA)|1 |
44
-|[RBM38](RBM38)|2 |
38
+|[ACTB](../ACTB)|1 |
39
+|[ARID1A](../ARID1A)|1 |
40
+|[DNAH12](../DNAH12)|2 |
41
+|[HLA-B](../HLA-B)|1 |
42
+|[IKBKB](../IKBKB)|2 |
43
+|[NFKBIA](../NFKBIA)|1 |
44
+|[RBM38](../RBM38)|2 |
45 45
46 46
# Details
47 47
papers/wildaInactivationARFMDM2p53Pathway2004.md
... ...
@@ -35,7 +35,7 @@ All other BL studies, BL Tier 2, 157
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[TP53](TP53)|1 |
38
+|[TP53](../TP53)|1 |
39 39
40 40
# Details
41 41
papers/wuGeneticHeterogeneityPrimary2016.md
... ...
@@ -35,7 +35,7 @@ All other MCL studies, MCL Tier 2, 46
35 35
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38
-|[CARD11](CARD11)|1 |
38
+|[CARD11](../CARD11)|1 |
39 39
40 40
# Details
41 41
papers/yanBCRTLRSignaling2012a.md
... ...
@@ -35,8 +35,8 @@ All other MZL studies, MZL Tier 2, 74
35 35
36 36
|New gene|MZL tier|
37 37
|:-|:-:|
38
-|[CARD11](CARD11)|1 |
39
-|[MYD88](MYD88)|1 |
38
+|[CARD11](../CARD11)|1 |
39
+|[MYD88](../MYD88)|1 |
40 40
41 41
# Details
42 42
papers/yildizActivatingSTAT6Mutations2015c.md
... ...
@@ -36,7 +36,7 @@ All other DLBCL studies, DLBCL Tier 2, 198
36 36
37 37
|New gene|DLBCL tier|FL tier|
38 38
|:-|:-:|:-:|
39
-|[STAT6](STAT6)|1 |1 |
39
+|[STAT6](../STAT6)|1 |1 |
40 40
41 41
# Details
42 42
papers/zhangGeneticHeterogeneityDiffuse2013.md
... ...
@@ -35,25 +35,25 @@ All other DLBCL studies, DLBCL Tier 2, 190
35 35
36 36
|New gene|DLBCL tier|
37 37
|:-|:-:|
38
-|[ARID1A](ARID1A)|1 |
39
-|[FBXW7](FBXW7)|1 |
40
-|[HIST1H3B](HIST1H3B)|1 |
41
-|[INO80](INO80)|2 |
42
-|[JAK1](JAK1)|2 |
43
-|[JAK3](JAK3)|2 |
44
-|[KLHL14](KLHL14)|1 |
45
-|[KMT2C](KMT2C)|1 |
46
-|[MGA](MGA)|1 |
47
-|[MTOR](MTOR)|1 |
48
-|[PIK3R1](PIK3R1)|2 |
49
-|[POU2F2](POU2F2)|1 |
50
-|[SETD2](SETD2)|2 |
51
-|[SMARCA4](SMARCA4)|1 |
52
-|[STAT5B](STAT5B)|2 |
53
-|[UBR5](UBR5)|2 |
54
-|[ZEB2](ZEB2)|2 |
55
-|[ZNF292](ZNF292)|1 |
56
-|[ZNF608](ZNF608)|1 |
38
+|[ARID1A](../ARID1A)|1 |
39
+|[FBXW7](../FBXW7)|1 |
40
+|[HIST1H3B](../HIST1H3B)|1 |
41
+|[INO80](../INO80)|2 |
42
+|[JAK1](../JAK1)|2 |
43
+|[JAK3](../JAK3)|2 |
44
+|[KLHL14](../KLHL14)|1 |
45
+|[KMT2C](../KMT2C)|1 |
46
+|[MGA](../MGA)|1 |
47
+|[MTOR](../MTOR)|1 |
48
+|[PIK3R1](../PIK3R1)|2 |
49
+|[POU2F2](../POU2F2)|1 |
50
+|[SETD2](../SETD2)|2 |
51
+|[SMARCA4](../SMARCA4)|1 |
52
+|[STAT5B](../STAT5B)|2 |
53
+|[UBR5](../UBR5)|2 |
54
+|[ZEB2](../ZEB2)|2 |
55
+|[ZNF292](../ZNF292)|1 |
56
+|[ZNF608](../ZNF608)|1 |
57 57
58 58
# Details
59 59
papers/zhangGenomicLandscapeMantle2014.md
... ...
@@ -35,34 +35,34 @@ All other MCL studies, MCL Tier 2, 20
35 35
36 36
|New gene|MCL tier|
37 37
|:-|:-:|
38
-|[ANK2](ANK2)|2 |
39
-|[ATP11C](ATP11C)|2 |
40
-|[CDH8](CDH8)|2 |
41
-|[COL11A1](COL11A1)|2 |
42
-|[COL16A1](COL16A1)|2 |
43
-|[CTNNA2](CTNNA2)|2 |
44
-|[DHDH](DHDH)|2 |
45
-|[DLC1](DLC1)|2 |
46
-|[EIF2AK4](EIF2AK4)|2 |
47
-|[ESX1](ESX1)|2 |
48
-|[FAT4](FAT4)|2 |
49
-|[GRIN2A](GRIN2A)|2 |
50
-|[HEPH](HEPH)|2 |
51
-|[KMT2C](KMT2C)|2 |
52
-|[MRGPRF](MRGPRF)|2 |
53
-|[NIN](NIN)|2 |
54
-|[OGDHL](OGDHL)|2 |
55
-|[PCDHB2](PCDHB2)|2 |
56
-|[PLXNB3](PLXNB3)|2 |
57
-|[POT1](POT1)|1 |
58
-|[RB1](RB1)|1 |
59
-|[ROBO2](ROBO2)|2 |
60
-|[SALL3](SALL3)|2 |
61
-|[SI](SI)|2 |
62
-|[SMC1A](SMC1A)|2 |
63
-|[TBC1D26](TBC1D26)|2 |
64
-|[ZNF117](ZNF117)|2 |
65
-|[ZNF296](ZNF296)|2 |
38
+|[ANK2](../ANK2)|2 |
39
+|[ATP11C](../ATP11C)|2 |
40
+|[CDH8](../CDH8)|2 |
41
+|[COL11A1](../COL11A1)|2 |
42
+|[COL16A1](../COL16A1)|2 |
43
+|[CTNNA2](../CTNNA2)|2 |
44
+|[DHDH](../DHDH)|2 |
45
+|[DLC1](../DLC1)|2 |
46
+|[EIF2AK4](../EIF2AK4)|2 |
47
+|[ESX1](../ESX1)|2 |
48
+|[FAT4](../FAT4)|2 |
49
+|[GRIN2A](../GRIN2A)|2 |
50
+|[HEPH](../HEPH)|2 |
51
+|[KMT2C](../KMT2C)|2 |
52
+|[MRGPRF](../MRGPRF)|2 |
53
+|[NIN](../NIN)|2 |
54
+|[OGDHL](../OGDHL)|2 |
55
+|[PCDHB2](../PCDHB2)|2 |
56
+|[PLXNB3](../PLXNB3)|2 |
57
+|[POT1](../POT1)|1 |
58
+|[RB1](../RB1)|1 |
59
+|[ROBO2](../ROBO2)|2 |
60
+|[SALL3](../SALL3)|2 |
61
+|[SI](../SI)|2 |
62
+|[SMC1A](../SMC1A)|2 |
63
+|[TBC1D26](../TBC1D26)|2 |
64
+|[ZNF117](../ZNF117)|2 |
65
+|[ZNF296](../ZNF296)|2 |
66 66
67 67
# Details
68 68
papers/zhouSporadicEndemicBurkitt2019.md
... ...
@@ -35,7 +35,7 @@ All other BL studies, BL Tier 2, 156
35 35
36 36
|New gene|BL tier|
37 37
|:-|:-:|
38
-|[KMT2C](KMT2C)|2 |
38
+|[KMT2C](../KMT2C)|2 |
39 39
40 40
# Details
41 41